reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD001261-bib-0001,"Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, et al. ",Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi: a preliminary report, New England Journal of Medicine ,1987,317,    ,['citation-journal']," Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi: a preliminary report.  New England Journal of Medicine 1987;317(18):1101‐4. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM198710293171801', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+typhoid+fever+in+Nepal+with+the+Vi+capsular+polysaccharide+of+Salmonella+typhi:+a+preliminary+report+&author=IL+Acharya&author=CU+Lowe&author=R+Thapa&author=VL+Gurubacharya&author=MB+Shrestha&author=M+Cadoz&publication_year=1987&hl=en']",,https://doi.org/10.1056/NEJM198710293171801, Acharya 1987 NPL {published data only}  ,included,CD001261-bbs2-0001,
CD001261-bib-0002,"Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. ",Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric coated capsules in a controlled field trial, Vaccine ,1990,8,    ,['citation-journal']," Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric coated capsules in a controlled field trial.  Vaccine 1990;8(1):81‐4. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0264-410X(90)90183-M', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+one+or+two+doses+of+Ty21a+Salmonella+typhi+vaccine+in+enteric+coated+capsules+in+a+controlled+field+trial+&author=RE+Black&author=MM+Levine&author=C+Ferreccio&author=ML+Clements&author=C+Lanata&author=J+Rooney&publication_year=1990&hl=en']",,https://doi.org/10.1016/0264-410X(90)90183-M, Black 1990i CHL {published data only}  ,included,CD001261-bbs2-0002,
CD001261-bib-0003,"Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC. ",Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B, Clinical Infectious Diseases ,2007,45,    ,['citation-journal']," Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.  Clinical Infectious Diseases 2007;45(Suppl 1):S24‐28. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1086/518141', 'https://scholar.google.com/scholar_lookup?title=Ty21a+live+oral+typhoid+vaccine+and+prevention+of+paratyphoid+fever+caused+by+Salmonella+enterica+Serovar+Paratyphi+B+&author=MM+Levine&author=C+Ferreccio&author=RE+Black&author=R+Lagos&author=O+SanMartin&author=WC+Blackwelder&publication_year=2007&hl=en']",,https://doi.org/10.1086/518141, Black 1990i CHL {published data only}  ,included,CD001261-bbs2-0002,
CD001261-bib-0004,"Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. ",Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric‐coated capsules in a controlled field trial, Vaccine ,1990,8,    ,['citation-journal']," Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric‐coated capsules in a controlled field trial.  Vaccine 1990;8(1):81‐4. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0264-410X(90)90183-M', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+one+or+two+doses+of+Ty21a+Salmonella+typhi+vaccine+in+enteric‐coated+capsules+in+a+controlled+field+trial+&author=RE+Black&author=MM+Levine&author=C+Ferreccio&author=ML+Clements&author=C+Lanata&author=J+Rooney&publication_year=1990&hl=en']",,https://doi.org/10.1016/0264-410X(90)90183-M, Black 1990ii CHL {published data only}  ,included,CD001261-bbs2-0003,
CD001261-bib-0005,"Cryz SJ, Vanprapar N, Thisyakorn U, Olanratmanee T, Losonsky G, Levine MM, et al. ",Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children, Infection and Immunity ,1993,61,    ,['citation-journal']," Cryz SJ, Vanprapar N, Thisyakorn U, Olanratmanee T, Losonsky G, Levine MM, et al. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.  Infection and Immunity 1993;61(3):1149‐51. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/iai.61.3.1149-1151.1993', 'https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+Salmonella+typhi+Ty21a+vaccine+in+young+Thai+children&author=SJ+Cryz&author=N+Vanprapar&author=U+Thisyakorn&author=T+Olanratmanee&author=G+Losonsky&author=MM+Levine&publication_year=1993&hl=en']",,https://doi.org/10.1128/iai.61.3.1149-1151.1993, Cryz 1993 THA {published data only}  ,included,CD001261-bbs2-0004,
CD001261-bib-0006,"Keitel WA, Bond NL, Zahradnik JM, Cramton TA, Robbins JB. ",Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines, Vaccine ,1994,12,    ,['citation-journal']," Keitel WA, Bond NL, Zahradnik JM, Cramton TA, Robbins JB. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines.  Vaccine 1994;12(3):195‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0264-410X(94)90194-5', 'https://scholar.google.com/scholar_lookup?title=Clinical+and+serological+responses+following+primary+and+booster+immunization+with+Salmonella+typhi+Vi+capsular+polysaccharide+vaccines+&author=WA+Keitel&author=NL+Bond&author=JM+Zahradnik&author=TA+Cramton&author=JB+Robbins&publication_year=1994&hl=en']",,https://doi.org/10.1016/0264-410X(94)90194-5, Keitel 1994 USA {published data only}  ,included,CD001261-bbs2-0005,
CD001261-bib-0007,"Khan I, Soofi S, Ochiai R, Habib M, Sahito S, Nizami S, et al. ","Effectiveness of Vi capsular polysaccharide vaccine among children: a cluster randomised trial in Karachi, Pakistan", Vaccine ,2012,30,    ,['citation-journal']," Khan I, Soofi S, Ochiai R, Habib M, Sahito S, Nizami S, et al. Effectiveness of Vi capsular polysaccharide vaccine among children: a cluster randomised trial in Karachi, Pakistan.  Vaccine 2012;30(36):5389‐95. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.vaccine.2012.06.015', 'https://scholar.google.com/scholar_lookup?title=Effectiveness+of+Vi+capsular+polysaccharide+vaccine+among+children:+a+cluster+randomised+trial+in+Karachi,+Pakistan+&author=I+Khan&author=S+Soofi&author=R+Ochiai&author=M+Habib&author=S+Sahito&author=S+Nizami&publication_year=2012&hl=en']",,https://doi.org/10.1016/j.vaccine.2012.06.015, Khan 2012 PAK {published and unpublished data}  ,included,CD001261-bbs2-0006,
CD001261-bib-0008,"Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, et al. ",Protective activity of Vi capsular polysaccharide vaccine against typhoid fever, Lancet ,1987,2,    ,['citation-journal']," Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.  Lancet 1987;2(8569):1165‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(87)91316-X', 'https://scholar.google.com/scholar_lookup?title=Protective+activity+of+Vi+capsular+polysaccharide+vaccine+against+typhoid+fever&author=KP+Klugman&author=IT+Gilbertson&author=HJ+Koornhof&author=JB+Robbins&author=R+Schneerson&author=D+Schulz&publication_year=1987&hl=en']",,https://doi.org/10.1016/S0140-6736(87)91316-X, Klugman 1987 ZAF {published data only}  ,included,CD001261-bbs2-0007,
CD001261-bib-0009,"Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. ","Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization", Vaccine ,1996,14,    ,['citation-journal']," Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization.  Vaccine 1996;14(5):435‐8. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0264-410X(95)00186-5', 'https://scholar.google.com/scholar_lookup?title=Immunogenicity,+efficacy+and+serological+correlate+of+protection+of+Salmonella+typhi+Vi+capsular+polysaccharide+vaccine+three+years+after+immunization+&author=KP+Klugman&author=HJ+Koornhof&author=JB+Robbins&author=NN+Cam&publication_year=1996&hl=en']",,https://doi.org/10.1016/0264-410X(95)00186-5, Klugman 1987 ZAF {published data only}  ,included,CD001261-bbs2-0007,
CD001261-bib-0010,"Levine MM, Black RE, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. ",The efficacy of attenuated Salmonella Typhi oral vaccine strain TY21A evaluated in controlled field trials,,1986,,    ,['citation-other']," Levine MM, Black RE, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. The efficacy of attenuated Salmonella Typhi oral vaccine strain TY21A evaluated in controlled field trials. Development of Vaccines and Drugs Against Diarrhea. 11th Noble Conference; 1985; Stockholm. Lund, Sweden: Studentlitteratur, 1986:90‐101. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+efficacy+of+attenuated+Salmonella+Typhi+oral+vaccine+strain+TY21A+evaluated+in+controlled+field+trials+&author=MM+Levine&author=RE+Black&author=C+Ferreccio&author=ML+Clements&author=C+Lanata&author=J+Rooney&publication_year=1986&hl=en']",,, Levine 1986i CHL {published data only}  ,included,CD001261-bbs2-0008,
CD001261-bib-0011,"Levine MM, Black RE, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. ",The efficacy of attenuated Salmonella typhi oral vaccine strain TY21A evaluated in controlled field trials,Development of Vaccines and Drugs Against Diarrhea. 11th Noble Conference; 1985; Stockholm,1986,,    ,['citation-book']," Levine MM, Black RE, Ferreccio C, Clements ML, Lanata C, Rooney J, et al. The efficacy of attenuated Salmonella typhi oral vaccine strain TY21A evaluated in controlled field trials. In: Holmgren J, Lindberg A, Möllby R editor(s). Development of Vaccines and Drugs Against Diarrhea. 11th Noble Conference; 1985; Stockholm. Lund, Sweden: Studentlitteratur, 1986:90‐101. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+efficacy+of+attenuated+Salmonella+typhi+oral+vaccine+strain+TY21A+evaluated+in+controlled+field+trials+&author=MM+Levine&author=RE+Black&author=C+Ferreccio&author=ML+Clements&author=C+Lanata&author=J+Rooney&publication_year=1986&hl=en']",,, Levine 1986ii CHL {published data only}  ,included,CD001261-bbs2-0009,
CD001261-bib-0012,"Germanier R, Levine MM. ",The live oral typhoid vaccine Ty21a: recent field trial results, Collana Monografica ,1986,3,    ,['citation-journal']," Germanier R, Levine MM. The live oral typhoid vaccine Ty21a: recent field trial results.  Collana Monografica 1986;3(1‐2):19‐22. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+live+oral+typhoid+vaccine+Ty21a:+recent+field+trial+results&author=R+Germanier&author=MM+Levine&publication_year=1986&hl=en']",,, Levine 1987i CHL {published data only}  ,included,CD001261-bbs2-0010,
CD001261-bib-0013,"Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. ","Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine", Vaccine ,1999,17,    ,['citation-journal']," Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.  Vaccine 1999;17(Suppl 2):22‐7. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0264-410X(99)00231-5', 'https://scholar.google.com/scholar_lookup?title=Duration+of+efficacy+of+Ty21a,+attenuated+Salmonella+typhi+live+oral+vaccine&author=MM+Levine&author=C+Ferreccio&author=P+Abrego&author=OS+Martin&author=E+Ortiz&author=S+Cryz&publication_year=1999&hl=en']",,https://doi.org/10.1016/S0264-410X(99)00231-5, Levine 1987i CHL {published data only}  ,included,CD001261-bbs2-0010,
CD001261-bib-0014,"Levine MM, Ferreccio C, Black RE, Germanier R. ",Large‐scale field trial of Ty21a live oral typhoid vaccine in enteric‐coated capsule formulation, Lancet ,1987,1,    ,['citation-journal']," Levine MM, Ferreccio C, Black RE, Germanier R. Large‐scale field trial of Ty21a live oral typhoid vaccine in enteric‐coated capsule formulation.  Lancet 1987;1(8541):1049‐52. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(87)90480-6', 'https://scholar.google.com/scholar_lookup?title=Large‐scale+field+trial+of+Ty21a+live+oral+typhoid+vaccine+in+enteric‐coated+capsule+formulation+&author=MM+Levine&author=C+Ferreccio&author=RE+Black&author=R+Germanier&publication_year=1987&hl=en']",,https://doi.org/10.1016/S0140-6736(87)90480-6, Levine 1987i CHL {published data only}  ,included,CD001261-bbs2-0010,
CD001261-bib-0015,"Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC. ",Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B, Clinical Infectious Diseases ,2007,45,    ,['citation-journal']," Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.  Clinical Infectious Diseases 2007;45(Suppl 1):S24‐28. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1086/518141', 'https://scholar.google.com/scholar_lookup?title=Ty21a+live+oral+typhoid+vaccine+and+prevention+of+paratyphoid+fever+caused+by+Salmonella+enterica+Serovar+Paratyphi+B+&author=MM+Levine&author=C+Ferreccio&author=RE+Black&author=R+Lagos&author=O+SanMartin&author=WC+Blackwelder&publication_year=2007&hl=en']",,https://doi.org/10.1086/518141, Levine 1987i CHL {published data only}  ,included,CD001261-bbs2-0010,
CD001261-bib-0016,"Levine MM, Tacket CO, Herrington D, Losonsky G, Murphy J, Ferreccio C. ",The current status of typhoid vaccine development and clinical trials with typhoid vaccines, Southeast Asian Journal of Tropical Medicine and Public Health ,1988,19,    ,['citation-journal']," Levine MM, Tacket CO, Herrington D, Losonsky G, Murphy J, Ferreccio C. The current status of typhoid vaccine development and clinical trials with typhoid vaccines.  Southeast Asian Journal of Tropical Medicine and Public Health 1988;19(3):459‐69. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+current+status+of+typhoid+vaccine+development+and+clinical+trials+with+typhoid+vaccines+&author=MM+Levine&author=CO+Tacket&author=D+Herrington&author=G+Losonsky&author=J+Murphy&author=C+Ferreccio&publication_year=1988&hl=en']",,, Levine 1987i CHL {published data only}  ,included,CD001261-bbs2-0010,
CD001261-bib-0017,"Levine MM, Taylor DN, Ferreccio C. ",Typhoid vaccines come of age, Pediatric Infectious Disease Journal ,1989,8,    ,['citation-journal']," Levine MM, Taylor DN, Ferreccio C. Typhoid vaccines come of age.  Pediatric Infectious Disease Journal 1989;8(6):374‐81. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00006454-198906000-00010', 'https://scholar.google.com/scholar_lookup?title=Typhoid+vaccines+come+of+age&author=MM+Levine&author=DN+Taylor&author=C+Ferreccio&publication_year=1989&hl=en']",,https://doi.org/10.1097/00006454-198906000-00010, Levine 1987i CHL {published data only}  ,included,CD001261-bbs2-0010,
CD001261-bib-0018,"Levine MM, Taylor DN, Ferreccio C. ",Typhoid vaccines come of age, Pediatric Infectious Disease Journal ,1989,8,    ,['citation-journal']," Levine MM, Taylor DN, Ferreccio C. Typhoid vaccines come of age.  Pediatric Infectious Disease Journal 1989;8(6):374‐81. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00006454-198906000-00010', 'https://scholar.google.com/scholar_lookup?title=Typhoid+vaccines+come+of+age&author=MM+Levine&author=DN+Taylor&author=C+Ferreccio&publication_year=1989&hl=en']",,https://doi.org/10.1097/00006454-198906000-00010, Levine 1987ii CHL {published data only}  ,included,CD001261-bbs2-0011,
CD001261-bib-0019,"Levine MM, Taylor DN, Ferreccio C. ",Typhoid vaccines come of age, Pediatric Infectious Disease Journal ,1989,8,    ,['citation-journal']," Levine MM, Taylor DN, Ferreccio C. Typhoid vaccines come of age.  Pediatric Infectious Disease Journal 1989;8(6):374‐81. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00006454-198906000-00010', 'https://scholar.google.com/scholar_lookup?title=Typhoid+vaccines+come+of+age&author=MM+Levine&author=DN+Taylor&author=C+Ferreccio&publication_year=1989&hl=en']",,https://doi.org/10.1097/00006454-198906000-00010, Levine 1987iii CHL {published data only}  ,included,CD001261-bbs2-0012,
CD001261-bib-0020,"Levine MM, Taylor DN, Ferreccio C. ",Typhoid vaccines come of age, Pediatric Infectious Disease Journal ,1989,8,    ,['citation-journal']," Levine MM, Taylor DN, Ferreccio C. Typhoid vaccines come of age.  Pediatric Infectious Disease Journal 1989;8(6):374‐81. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/00006454-198906000-00010', 'https://scholar.google.com/scholar_lookup?title=Typhoid+vaccines+come+of+age&author=MM+Levine&author=DN+Taylor&author=C+Ferreccio&publication_year=1989&hl=en']",,https://doi.org/10.1097/00006454-198906000-00010, Levine 1987iv CHL {published data only}  ,included,CD001261-bbs2-0013,
CD001261-bib-0021,"Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. ","Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine", Vaccine ,1999,17,    ,['citation-journal']," Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.  Vaccine 1999;17(Suppl 2):22‐7. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0264-410X(99)00231-5', 'https://scholar.google.com/scholar_lookup?title=Duration+of+efficacy+of+Ty21a,+attenuated+Salmonella+typhi+live+oral+vaccine&author=MM+Levine&author=C+Ferreccio&author=P+Abrego&author=OS+Martin&author=E+Ortiz&author=S+Cryz&publication_year=1999&hl=en']",,https://doi.org/10.1016/S0264-410X(99)00231-5, Levine 1990i CHL {published data only}  ,included,CD001261-bbs2-0014,
CD001261-bib-0022,"Levine MM, Ferreccio C, Cryz S, Ortiz E. ",Comparison of enteric‐coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial, Lancet ,1990,336,    ,['citation-journal']," Levine MM, Ferreccio C, Cryz S, Ortiz E. Comparison of enteric‐coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial.  Lancet 1990;336(8720):891‐4. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+enteric‐coated+capsules+and+liquid+formulation+of+Ty21a+typhoid+vaccine+in+randomised+controlled+field+trial+&author=MM+Levine&author=C+Ferreccio&author=S+Cryz&author=E+Ortiz&publication_year=1990&hl=en']",,, Levine 1990i CHL {published data only}  ,included,CD001261-bbs2-0014,
CD001261-bib-0023,"Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. ","Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine", Vaccine ,1999,17,    ,['citation-journal']," Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.  Vaccine 1999;17(Suppl 2):22‐7. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0264-410X(99)00231-5', 'https://scholar.google.com/scholar_lookup?title=Duration+of+efficacy+of+Ty21a,+attenuated+Salmonella+typhi+live+oral+vaccine&author=MM+Levine&author=C+Ferreccio&author=P+Abrego&author=OS+Martin&author=E+Ortiz&author=S+Cryz&publication_year=1999&hl=en']",,https://doi.org/10.1016/S0264-410X(99)00231-5, Levine 1990ii CHL {published data only}  ,included,CD001261-bbs2-0015,
CD001261-bib-0024,"Levine MM, Ferreccio C, Cryz S, Ortiz E. ",Comparison of enteric‐coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial, Lancet ,1990,336,    ,['citation-journal']," Levine MM, Ferreccio C, Cryz S, Ortiz E. Comparison of enteric‐coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial.  Lancet 1990;336(8720):891‐4. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+enteric‐coated+capsules+and+liquid+formulation+of+Ty21a+typhoid+vaccine+in+randomised+controlled+field+trial+&author=MM+Levine&author=C+Ferreccio&author=S+Cryz&author=E+Ortiz&publication_year=1990&hl=en']",,, Levine 1990ii CHL {published data only}  ,included,CD001261-bbs2-0015,
CD001261-bib-0025,"Lanh MN, Van Bay P, Ho VA, Thanh TC, Lin FY, Bryla DA, et al. ",Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children, New England Journal of Medicine ,2003,349,    ,['citation-journal']," Lanh MN, Van Bay P, Ho VA, Thanh TC, Lin FY, Bryla DA, et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.  New England Journal of Medicine 2003;349(14):1390‐1. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM200310023491423', 'https://scholar.google.com/scholar_lookup?title=Persistent+efficacy+of+Vi+conjugate+vaccine+against+typhoid+fever+in+young+children&author=MN+Lanh&author=P+Bay&author=VA+Ho&author=TC+Thanh&author=FY+Lin&author=DA+Bryla&publication_year=2003&hl=en']",,https://doi.org/10.1056/NEJM200310023491423, Lin 2001 VNM {published data only}  ,included,CD001261-bbs2-0016,
CD001261-bib-0026,"Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, et al. ",The efficacy of a Salmonella typhi Vi conjugate vaccine in two‐to‐five‐year‐old children, New England Journal of Medicine ,2001,344,    ,['citation-journal']," Lin FY, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two‐to‐five‐year‐old children.  New England Journal of Medicine 2001;344(17):1263‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM200104263441701', 'https://scholar.google.com/scholar_lookup?title=The+efficacy+of+a+Salmonella+typhi+Vi+conjugate+vaccine+in+two‐to‐five‐year‐old+children&author=FY+Lin&author=VA+Ho&author=HB+Khiem&author=DD+Trach&author=PV+Bay&author=TC+Thanh&publication_year=2001&hl=en']",,https://doi.org/10.1056/NEJM200104263441701, Lin 2001 VNM {published data only}  ,included,CD001261-bbs2-0016,
CD001261-bib-0027,"Mitra M, Shah N, Ghosh A, Chatterjee S, Kaur I, Bhattacharya N, et al. ",Efficacy and safety of vi‐tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study, Human Vaccines & Immunotherapeutics ,2016,12,    ,['citation-journal']," Mitra M, Shah N, Ghosh A, Chatterjee S, Kaur I, Bhattacharya N, et al. Efficacy and safety of vi‐tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.  Human Vaccines & Immunotherapeutics 2016;12(4):939‐45. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1080/21645515.2015.1117715', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+vi‐tetanus+toxoid+conjugated+typhoid+vaccine+(PedaTyph™)+in+Indian+children:+School+based+cluster+randomized+study+&author=M+Mitra&author=N+Shah&author=A+Ghosh&author=S+Chatterjee&author=I+Kaur&author=N+Bhattacharya&publication_year=2016&hl=en']",,https://doi.org/10.1080/21645515.2015.1117715, Mitra 2016 IND {published data only}  ,included,CD001261-bbs2-0017,
CD001261-bib-0028,"Olanratmanee T, Levine M, Losonsky G, Thisyakorn V, Cryz SJ. ",Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4‐ to 6‐year‐old Thai children, Journal of Infectious Diseases ,1992,166,    ,['citation-journal']," Olanratmanee T, Levine M, Losonsky G, Thisyakorn V, Cryz SJ. Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4‐ to 6‐year‐old Thai children.  Journal of Infectious Diseases 1992;166(2):451‐2. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/infdis/166.2.451', 'https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+Salmonella+typhi+Ty21a+liquid+formulation+vaccine+in+4‐+to+6‐year‐old+Thai+children+&author=T+Olanratmanee&author=M+Levine&author=G+Losonsky&author=V+Thisyakorn&author=SJ+Cryz&publication_year=1992&hl=en']",,https://doi.org/10.1093/infdis/166.2.451, Olanratmanee 1992 THA {published data only}  ,included,CD001261-bbs2-0018,
CD001261-bib-0029,"Simanjuntak CH, Paleologo FP, Punjabi NH, Darmowigoto R, Soeprawoto, Totosudirjo H, et al. ",Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine, Lancet ,1991,338,    ,['citation-journal']," Simanjuntak CH, Paleologo FP, Punjabi NH, Darmowigoto R, Soeprawoto, Totosudirjo H, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.  Lancet 1991;338(8774):1055‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0140-6736(91)91910-M', 'https://scholar.google.com/scholar_lookup?title=Oral+immunisation+against+typhoid+fever+in+Indonesia+with+Ty21a+vaccine&author=CH+Simanjuntak&author=FP+Paleologo&author=NH+Punjabi&author=R+Darmowigoto&author=+Soeprawoto&author=H+Totosudirjo&publication_year=1991&hl=en']",,https://doi.org/10.1016/0140-6736(91)91910-M, Simanjuntak 1991i IDN {published data only}  ,included,CD001261-bbs2-0019,
CD001261-bib-0030,"Simanjuntak CH, Paleologo FP, Punjabi NH, Darmowigoto R, Soeprawoto, Totosudirjo H, et al. ",Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine, Lancet ,1991,338,    ,['citation-journal']," Simanjuntak CH, Paleologo FP, Punjabi NH, Darmowigoto R, Soeprawoto, Totosudirjo H, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.  Lancet 1991;338(8774):1055‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0140-6736(91)91910-M', 'https://scholar.google.com/scholar_lookup?title=Oral+immunisation+against+typhoid+fever+in+Indonesia+with+Ty21a+vaccine&author=CH+Simanjuntak&author=FP+Paleologo&author=NH+Punjabi&author=R+Darmowigoto&author=+Soeprawoto&author=H+Totosudirjo&publication_year=1991&hl=en']",,https://doi.org/10.1016/0140-6736(91)91910-M, Simanjuntak 1991ii IDN {published data only}  ,included,CD001261-bbs2-0020,
CD001261-bib-0031,"Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, et al. ",A cluster‐randomized effectiveness trial of Vi typhoid vaccine in India, New England Journal of Medicine ,2009,361,    ,['citation-journal']," Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, et al. A cluster‐randomized effectiveness trial of Vi typhoid vaccine in India.  New England Journal of Medicine 2009;361(4):335‐44. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa0807521', 'https://scholar.google.com/scholar_lookup?title=A+cluster‐randomized+effectiveness+trial+of+Vi+typhoid+vaccine+in+India&author=D+Sur&author=RL+Ochiai&author=SK+Bhattacharya&author=NK+Ganguly&author=M+Ali&author=B+Manna&publication_year=2009&hl=en']",,https://doi.org/10.1056/NEJMoa0807521, Sur 2009 IND {published and unpublished data}  ,included,CD001261-bbs2-0021,
CD001261-bib-0032,"Wahdan MH, Sérié C, Cerisier Y, Sallam S, Germanier R. ",A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three‐year results, Journal of Infectious Diseases ,1982,145,    ,['citation-journal']," Wahdan MH, Sérié C, Cerisier Y, Sallam S, Germanier R. A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three‐year results.  Journal of Infectious Diseases 1982;145(3):292‐5. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/infdis/145.3.292', 'https://scholar.google.com/scholar_lookup?title=A+controlled+field+trial+of+live+Salmonella+typhi+strain+Ty+21a+oral+vaccine+against+typhoid:+three‐year+results+&author=MH+Wahdan&author=C+Sérié&author=Y+Cerisier&author=S+Sallam&author=R+Germanier&publication_year=1982&hl=en']",,https://doi.org/10.1093/infdis/145.3.292, Wahdan 1980a EGY {published data only}  ,included,CD001261-bbs2-0022,
CD001261-bib-0033,"Wahdan MH, Sérié C, Germanier R, Lackany A, Cerisier Y, Guerin N, et al. ",A controlled field trial of live oral typhoid vaccine Ty21a, Bulletin of the World Health Organization ,1980,58,    ,['citation-journal']," Wahdan MH, Sérié C, Germanier R, Lackany A, Cerisier Y, Guerin N, et al. A controlled field trial of live oral typhoid vaccine Ty21a.  Bulletin of the World Health Organization 1980;58(3):469‐74. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+controlled+field+trial+of+live+oral+typhoid+vaccine+Ty21a&author=MH+Wahdan&author=C+Sérié&author=R+Germanier&author=A+Lackany&author=Y+Cerisier&author=N+Guerin&publication_year=1980&hl=en']",,, Wahdan 1980a EGY {published data only}  ,included,CD001261-bbs2-0022,
CD001261-bib-0034,"Wahdan MH, Sérié C, Cerisier Y, Sallam S, Germanier R. ",A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three year results, Journal of Infectious Diseases ,1982,145,    ,['citation-journal']," Wahdan MH, Sérié C, Cerisier Y, Sallam S, Germanier R. A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three year results.  Journal of Infectious Diseases 1982;145(3):292‐5. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/infdis/145.3.292', 'https://scholar.google.com/scholar_lookup?title=A+controlled+field+trial+of+live+Salmonella+typhi+strain+Ty+21a+oral+vaccine+against+typhoid:+three+year+results+&author=MH+Wahdan&author=C+Sérié&author=Y+Cerisier&author=S+Sallam&author=R+Germanier&publication_year=1982&hl=en']",,https://doi.org/10.1093/infdis/145.3.292, Wahdan 1980b EGY {published data only}  ,included,CD001261-bbs2-0023,
CD001261-bib-0035,"Wahdan MH, Sérié C, Germanier R, Lackany A, Cerisier Y, Guerin N, et al. ",A controlled field trial of live oral typhoid vaccine Ty21a, Bulletin of the World Health Organization ,1980,58,    ,['citation-journal']," Wahdan MH, Sérié C, Germanier R, Lackany A, Cerisier Y, Guerin N, et al. A controlled field trial of live oral typhoid vaccine Ty21a.  Bulletin of the World Health Organization 1980;58(3):469‐74. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+controlled+field+trial+of+live+oral+typhoid+vaccine+Ty21a&author=MH+Wahdan&author=C+Sérié&author=R+Germanier&author=A+Lackany&author=Y+Cerisier&author=N+Guerin&publication_year=1980&hl=en']",,, Wahdan 1980b EGY {published data only}  ,included,CD001261-bbs2-0023,
CD001261-bib-0036,"Acosta CJ, Hong‐Hui Y, Ning W, Qion G, Qun D, Xiaolei M, et al. ","Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow‐up", Vaccine ,2005,23,    ,['citation-journal']," Acosta CJ, Hong‐Hui Y, Ning W, Qion G, Qun D, Xiaolei M, et al. Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow‐up.  Vaccine 2005;23(48‐9):5618‐23. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.vaccine.2005.06.035', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+a+locally+produced,+Chinese+Vi+polysaccharide+typhoid+fever+vaccine+during+six+years+of+follow‐up+&author=CJ+Acosta&author=Y+Hong‐Hui&author=W+Ning&author=G+Qion&author=D+Qun&author=M+Xiaolei&publication_year=2005&hl=en']",,https://doi.org/10.1016/j.vaccine.2005.06.035, Wang 1997 CHN {published data only}  ,included,CD001261-bbs2-0024,
CD001261-bib-0037,"Wang ZG, Zhou WZ, Shi J. ",Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine, Zhonghua Liu Xing Bing Xue Za Zhi ,1997,18,    ,['citation-journal']," Wang ZG, Zhou WZ, Shi J. Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine.  Zhonghua Liu Xing Bing Xue Za Zhi 1997;18(1):26‐9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+side+effects+following+immunization+with+Salmonella+typhi+Vi+capsular+polysaccharide+vaccine+&author=ZG+Wang&author=WZ+Zhou&author=J+Shi&publication_year=1997&hl=en']",,, Wang 1997 CHN {published data only}  ,included,CD001261-bbs2-0024,
CD001261-bib-0038,"Acosta CJ, Hong‐Hui Y, Ning W, Qion G, Qun D, Xiaolei M, et al. ","Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow‐up", Vaccine ,2005,23,    ,['citation-journal']," Acosta CJ, Hong‐Hui Y, Ning W, Qion G, Qun D, Xiaolei M, et al. Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow‐up.  Vaccine 2005;23(48‐9):5618‐23. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.vaccine.2005.06.035', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+a+locally+produced,+Chinese+Vi+polysaccharide+typhoid+fever+vaccine+during+six+years+of+follow‐up+&author=CJ+Acosta&author=Y+Hong‐Hui&author=W+Ning&author=G+Qion&author=D+Qun&author=M+Xiaolei&publication_year=2005&hl=en']",,https://doi.org/10.1016/j.vaccine.2005.06.035, Yang 2001 CHN {published data only}  ,included,CD001261-bbs2-0025,
CD001261-bib-0039,"Yang HH, Wu CG, Xie GZ, Gu QW, Wang BR, Wang LY, et al. ",Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south‐western China, Bulletin of the World Health Organization ,2001,79,    ,['citation-journal']," Yang HH, Wu CG, Xie GZ, Gu QW, Wang BR, Wang LY, et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south‐western China.  Bulletin of the World Health Organization 2001;79(7):625‐31. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Efficacy+trial+of+Vi+polysaccharide+vaccine+against+typhoid+fever+in+south‐western+China+&author=HH+Yang&author=CG+Wu&author=GZ+Xie&author=QW+Gu&author=BR+Wang&author=LY+Wang&publication_year=2001&hl=en']",,, Yang 2001 CHN {published data only}  ,included,CD001261-bbs2-0025,
CD001261-bib-0040,"Zhou WZ, Koo HW, Wang XY, Zhang J, Park JK, Zhu F, et al. ",Revaccination with locally‐produced Vi typhoid polysaccharide vaccine among Chinese school‐aged children: safety and immunogenicity findings, Paediatric Infectious Disease Journal ,2007,26,    ,['citation-journal']," Zhou WZ, Koo HW, Wang XY, Zhang J, Park JK, Zhu F, et al. Revaccination with locally‐produced Vi typhoid polysaccharide vaccine among Chinese school‐aged children: safety and immunogenicity findings.  Paediatric Infectious Disease Journal 2007;26(11):1001‐5. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/INF.0b013e31812565bc', 'https://scholar.google.com/scholar_lookup?title=Revaccination+with+locally‐produced+Vi+typhoid+polysaccharide+vaccine+among+Chinese+school‐aged+children:+safety+and+immunogenicity+findings+&author=WZ+Zhou&author=HW+Koo&author=XY+Wang&author=J+Zhang&author=JK+Park&author=F+Zhu&publication_year=2007&hl=en']",,https://doi.org/10.1097/INF.0b013e31812565bc, Zhou 2007 CHN {published data only}  ,included,CD001261-bbs2-0026,
CD001261-bib-0041,"Ali M, Sur D, Kim DR, Kanungo S, Bhattacharya SK, Manna B, et al. ","Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India", Vaccine ,2011,29,    ,['citation-journal']," Ali M, Sur D, Kim DR, Kanungo S, Bhattacharya SK, Manna B, et al. Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India.  Vaccine 2011;29(48):9051‐6. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.vaccine.2011.09.027', 'https://scholar.google.com/scholar_lookup?title=Impact+of+Vi+vaccination+on+spatial+patterns+of+typhoid+fever+in+the+slums+of+Kolkata,+India+&author=M+Ali&author=D+Sur&author=DR+Kim&author=S+Kanungo&author=SK+Bhattacharya&author=B+Manna&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.vaccine.2011.09.027, Ali 2011 {published data only}  ,excluded,CD001261-bbs2-0027, No relevant outcome measures 
CD001261-bib-0042,Arya SC. ,Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa, Vaccine ,1997,15,    ,['citation-journal'], Arya SC. Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.  Vaccine 1997;15(2):244. CENTRAL    Link to article     Google Scholar     ,"['', 'https://doi.org/10.1016/S0264-410X(96)00168-5', 'https://scholar.google.com/scholar_lookup?title=Efficacy+of+Salmonella+typhi+Vi+capsular+polysaccharide+vaccine+in+South+Africa&author=SC+Arya&publication_year=1997&hl=en']",,https://doi.org/10.1016/S0264-410X(96)00168-5, Arya 1997 {published data only}  ,excluded,CD001261-bbs2-0028, Letter; not an RCT 
CD001261-bib-0043,"Ashcroft MT, Ritchie JM, Nicholson CC. ",Controlled field trial in British Guiana school children of heat‐killed phenolized and acetone‐killed lyophilized vaccines, American Journal of Hygiene ,1964,79,    ,['citation-journal']," Ashcroft MT, Ritchie JM, Nicholson CC. Controlled field trial in British Guiana school children of heat‐killed phenolized and acetone‐killed lyophilized vaccines.  American Journal of Hygiene 1964;79(2):196‐206. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Controlled+field+trial+in+British+Guiana+school+children+of+heat‐killed+phenolized+and+acetone‐killed+lyophilized+vaccines+&author=MT+Ashcroft&author=JM+Ritchie&author=CC+Nicholson&publication_year=1964&hl=en']",,, Ashcroft 1967 {published data only}  ,excluded,CD001261-bbs2-0029," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0044,"Ashcroft MT, Singh B, Nicholson CC, Ritchie JM, Sobryan E, Williams F. ",A seven‐year field trial of two typhoid vaccines in Guyana, Lancet ,1967,2,    ,['citation-journal']," Ashcroft MT, Singh B, Nicholson CC, Ritchie JM, Sobryan E, Williams F. A seven‐year field trial of two typhoid vaccines in Guyana.  Lancet 1967;2(7525):1056‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(67)90335-2', 'https://scholar.google.com/scholar_lookup?title=A+seven‐year+field+trial+of+two+typhoid+vaccines+in+Guyana&author=MT+Ashcroft&author=B+Singh&author=CC+Nicholson&author=JM+Ritchie&author=E+Sobryan&author=F+Williams&publication_year=1967&hl=en']",,https://doi.org/10.1016/S0140-6736(67)90335-2, Ashcroft 1967 {published data only}  ,excluded,CD001261-bbs2-0029," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0045,Kasi AM. ,A controlled field trial of acetone‐dried and inactivated and heat‐phenol‐inactivated typhoid vaccines in British Guiana, Bulletin of the World Health Organization ,1964,30,    ,['citation-journal'], Kasi AM. A controlled field trial of acetone‐dried and inactivated and heat‐phenol‐inactivated typhoid vaccines in British Guiana.  Bulletin of the World Health Organization 1964;30(5):631‐4. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=A+controlled+field+trial+of+acetone‐dried+and+inactivated+and+heat‐phenol‐inactivated+typhoid+vaccines+in+British+Guiana+&author=AM+Kasi&publication_year=1964&hl=en']",,, Ashcroft 1967 {published data only}  ,excluded,CD001261-bbs2-0029," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0046,"Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, et al. ","Immunogenicity and safety of the Vi‐CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer‐blind, age de‐escalation, phase 2 trials", Lancet Infectious Diseases ,2014,14,    ,['citation-journal']," Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, et al. Immunogenicity and safety of the Vi‐CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer‐blind, age de‐escalation, phase 2 trials.  Lancet Infectious Diseases 2014;14(2):119‐29. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S1473-3099(13)70241-X', 'https://scholar.google.com/scholar_lookup?title=Immunogenicity+and+safety+of+the+Vi‐CRM197+conjugate+vaccine+against+typhoid+fever+in+adults,+children,+and+infants+in+south+and+southeast+Asia:+results+from+two+randomised,+observer‐blind,+age+de‐escalation,+phase+2+trials+&author=ZA+Bhutta&author=MR+Capeding&author=A+Bavdekar&author=E+Marchetti&author=S+Ariff&author=SB+Soofi&publication_year=2014&hl=en']",,https://doi.org/10.1016/S1473-3099(13)70241-X, Bhutta 2014 {published data only}  ,excluded,CD001261-bbs2-0030, No efficacy data yet for Vi‐CRM197 so according to protocol cannot include for side effects/safety only  
CD001261-bib-0047,"Black R, Levine MM, Young C, Rooney J, Levine S, Clements ML, et al. ","Immunogenicity of Ty21a attenuated ""Salmonella typhi"" given with sodium bicarbonate or in enteric‐coated capsules", Developments in Biological Standardization ,1983,53,    ,['citation-journal']," Black R, Levine MM, Young C, Rooney J, Levine S, Clements ML, et al. Immunogenicity of Ty21a attenuated ""Salmonella typhi"" given with sodium bicarbonate or in enteric‐coated capsules.  Developments in Biological Standardization 1983;53:9‐14. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+Ty21a+attenuated+']",,, Black 1983 {published data only}  ,excluded,CD001261-bbs2-0031, No relevant outcome measures 
CD001261-bib-0048,"Blohmke CJ, Hill J, Darton TC, Carvalho‐Burger M, Eustace A, Jones C, et al. ",Induction of cell cycle and NK cell responses by live‐attenuated oral vaccines against typhoid fever, Frontiers in Immunology ,2017,8,    ,['citation-journal']," Blohmke CJ, Hill J, Darton TC, Carvalho‐Burger M, Eustace A, Jones C, et al. Induction of cell cycle and NK cell responses by live‐attenuated oral vaccines against typhoid fever.  Frontiers in Immunology 2017;8:1276. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.3389/fimmu.2017.01276', 'https://scholar.google.com/scholar_lookup?title=Induction+of+cell+cycle+and+NK+cell+responses+by+live‐attenuated+oral+vaccines+against+typhoid+fever+&author=CJ+Blohmke&author=J+Hill&author=TC+Darton&author=M+Carvalho‐Burger&author=A+Eustace&author=C+Jones&publication_year=2017&hl=en']",,https://doi.org/10.3389/fimmu.2017.01276, Blomke 2017 {published data only}  ,excluded,CD001261-bbs2-0032, Additional info for Darton 2016 ‐ human challenge study – already excluded  
CD001261-bib-0049,"Bumann D, Metzger WG, Mansouri E, Palme O, Wendland M, Hurwitz R, et al. ",Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers, Vaccine ,2001,20,    ,['citation-journal']," Bumann D, Metzger WG, Mansouri E, Palme O, Wendland M, Hurwitz R, et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.  Vaccine 2001;20(5‐6):845‐52. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0264-410X(01)00391-7', 'https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+live+recombinant+Salmonella+enterica+serovar+Typhi+Ty21a+expressing+urease+A+and+B+from+Helicobacter+pylori+in+human+volunteers+&author=D+Bumann&author=WG+Metzger&author=E+Mansouri&author=O+Palme&author=M+Wendland&author=R+Hurwitz&publication_year=2001&hl=en']",,https://doi.org/10.1016/S0264-410X(01)00391-7, Bumann 2001 {published data only}  ,excluded,CD001261-bbs2-0033, Evaluated experimental live‐attenuated oral vaccine candidates; no efficacy trials of this vaccine  
CD001261-bib-0050,"Canh DG, Lin FY, Thiem VD, Trach DD, Trong ND, Mao ND, et al. ",Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2‐ to 5‐year‐old Vietnamese children, Infection and Immunity ,2004,72,    ,['citation-journal']," Canh DG, Lin FY, Thiem VD, Trach DD, Trong ND, Mao ND, et al. Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2‐ to 5‐year‐old Vietnamese children.  Infection and Immunity 2004;72(11):6586‐8. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/IAI.72.11.6586-6588.2004', 'https://scholar.google.com/scholar_lookup?title=Effect+of+dosage+on+immunogenicity+of+a+Vi+conjugate+vaccine+injected+twice+into+2‐+to+5‐year‐old+Vietnamese+children+&author=DG+Canh&author=FY+Lin&author=VD+Thiem&author=DD+Trach&author=ND+Trong&author=ND+Mao&publication_year=2004&hl=en']",,https://doi.org/10.1128/IAI.72.11.6586-6588.2004, Cahn 2004 {published data only}  ,excluded,CD001261-bbs2-0034, Study arms randomly assigned to receive different doses of same vaccine 
CD001261-bib-0054,Chuttani CS. ,Controlled field trials of three different oral killed typhoid vaccines in India, Developments in Biological Standardization ,1976,33,    ,['citation-journal'], Chuttani CS. Controlled field trials of three different oral killed typhoid vaccines in India.  Developments in Biological Standardization 1976;33:98‐101. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Controlled+field+trials+of+three+different+oral+killed+typhoid+vaccines+in+India&author=CS+Chuttani&publication_year=1976&hl=en']",,, Chuttani 1977 {published data only}  ,excluded,CD001261-bbs2-0035," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0051,"Chuttani CS, Prakash K, Gupta P, Grover V, Kumar A. ",Controlled field trial of a high‐dose oral killed typhoid vaccine in India, Bulletin of the World Health Organization ,1977,55,    ,['citation-journal']," Chuttani CS, Prakash K, Gupta P, Grover V, Kumar A. Controlled field trial of a high‐dose oral killed typhoid vaccine in India.  Bulletin of the World Health Organization 1977;55(5):643‐4. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Controlled+field+trial+of+a+high‐dose+oral+killed+typhoid+vaccine+in+India&author=CS+Chuttani&author=K+Prakash&author=P+Gupta&author=V+Grover&author=A+Kumar&publication_year=1977&hl=en']",,, Chuttani 1977 {published data only}  ,excluded,CD001261-bbs2-0035," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0052,"Chuttani CS, Prakash K, Vergese A, Gupta P, Chawla RK, Grover V, et al. ",Ineffectiveness of an oral killed typhoid vaccine in a field trial, Bulletin of the World Health Organization ,1973,48,    ,['citation-journal']," Chuttani CS, Prakash K, Vergese A, Gupta P, Chawla RK, Grover V, et al. Ineffectiveness of an oral killed typhoid vaccine in a field trial.  Bulletin of the World Health Organization 1973;48(6):754‐5. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Ineffectiveness+of+an+oral+killed+typhoid+vaccine+in+a+field+trial&author=CS+Chuttani&author=K+Prakash&author=A+Vergese&author=P+Gupta&author=RK+Chawla&author=V+Grover&publication_year=1973&hl=en']",,, Chuttani 1977 {published data only}  ,excluded,CD001261-bbs2-0035," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0053,"Chuttani CS, Prakash K, Vergese A, Sharma U, Singha P, Ray BG. ",Effectiveness of oral killed typhoid vaccine, Bulletin of the World Health Organization ,1971,45,    ,['citation-journal']," Chuttani CS, Prakash K, Vergese A, Sharma U, Singha P, Ray BG. Effectiveness of oral killed typhoid vaccine.  Bulletin of the World Health Organization 1971;45(4):445‐50. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effectiveness+of+oral+killed+typhoid+vaccine&author=CS+Chuttani&author=K+Prakash&author=A+Vergese&author=U+Sharma&author=P+Singha&author=BG+Ray&publication_year=1971&hl=en']",,, Chuttani 1977 {published data only}  ,excluded,CD001261-bbs2-0035," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0055,"Cordero‐Yap L, Rivera RG, Dispo AP, Mallabo J. ",Evaluation of a new Vi polysaccharide typhoid vaccine in children aged 2‐5 years,,2001,,    ,['citation-other']," Cordero‐Yap L, Rivera RG, Dispo AP, Mallabo J. Evaluation of a new Vi polysaccharide typhoid vaccine in children aged 2‐5 years. BioDrugs2001; Vol. 15, issue Suppl 1:27. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+a+new+Vi+polysaccharide+typhoid+vaccine+in+children+aged+2‐5+years&author=L+Cordero‐Yap&author=RG+Rivera&author=AP+Dispo&author=J+Mallabo&publication_year=2001&hl=en']",,, Cordero‐Yap 2001 {published data only}  ,excluded,CD001261-bbs2-0036, Compared 2 Vi polysaccharide vaccines made by 2 different companies 
CD001261-bib-0056,"Cryz SJ, Que JU, Levine MM, Wiedermann G, Kollaritsch H. ",Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)‐cholera (Vibrio cholerae CVD 103‐HgR) vaccine in healthy adults, Infection and Immunity ,1995,63,    ,['citation-journal']," Cryz SJ, Que JU, Levine MM, Wiedermann G, Kollaritsch H. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)‐cholera (Vibrio cholerae CVD 103‐HgR) vaccine in healthy adults.  Infection and Immunity 1995;63(4):1336‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/iai.63.4.1336-1339.1995', 'https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+a+live+oral+bivalent+typhoid+fever+(Salmonella+typhi+Ty21a)‐cholera+(Vibrio+cholerae+CVD+103‐HgR)+vaccine+in+healthy+adults+&author=SJ+Cryz&author=JU+Que&author=MM+Levine&author=G+Wiedermann&author=H+Kollaritsch&publication_year=1995&hl=en']",,https://doi.org/10.1128/iai.63.4.1336-1339.1995, Cryz 1995 {published data only}  ,excluded,CD001261-bbs2-0037, No relevant control group 
CD001261-bib-0057,"Cumberland NS, St Clair Roberts J, Arnold WS, Patel RK, Bowker CH. ",Typhoid Vi: a less reactogenic vaccine, Journal of International Medical Research ,1992,20,    ,['citation-journal']," Cumberland NS, St Clair Roberts J, Arnold WS, Patel RK, Bowker CH. Typhoid Vi: a less reactogenic vaccine.  Journal of International Medical Research 1992;20(3):247‐53. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1177/030006059202000306', 'https://scholar.google.com/scholar_lookup?title=Typhoid+Vi:+a+less+reactogenic+vaccine&author=NS+Cumberland&author=J+ClairRoberts&author=WS+Arnold&author=RK+Patel&author=CH+Bowker&publication_year=1992&hl=en']",,https://doi.org/10.1177/030006059202000306, Cumberland 1992 {published data only}  ,excluded,CD001261-bbs2-0038," Evaluated Vi vaccine versus inactivated whole‐cell vaccine, which is no longer in use  "
CD001261-bib-0058,"Darton TC, Jones C, Blohmke CJ, Waddington CS, Zhou L, Peters A, et al. ","Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a", PLOS Neglected Tropical Diseases ,2016,10,    ,['citation-journal']," Darton TC, Jones C, Blohmke CJ, Waddington CS, Zhou L, Peters A, et al. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.  PLOS Neglected Tropical Diseases 2016;10(8):e0004926. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pntd.0004926', 'https://scholar.google.com/scholar_lookup?title=Using+a+Human+Challenge+Model+of+Infection+to+Measure+Vaccine+Efficacy:+A+Randomised,+Controlled+Trial+Comparing+the+Typhoid+Vaccines+M01ZH09+with+Placebo+and+Ty21a+&author=TC+Darton&author=C+Jones&author=CJ+Blohmke&author=CS+Waddington&author=L+Zhou&author=A+Peters&publication_year=2016&hl=en']",,https://doi.org/10.1371/journal.pntd.0004926, Darton 2016 {published data only}  ,excluded,CD001261-bbs2-0039, Human challenge study 
CD001261-bib-0059,"Ferreccio C, Levine MM, Rodriguez H, Contreras R. ","Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric‐coated capsules: a field trial in an endemic area", Journal of Infectious Diseases ,1989,159,    ,['citation-journal']," Ferreccio C, Levine MM, Rodriguez H, Contreras R. Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric‐coated capsules: a field trial in an endemic area.  Journal of Infectious Diseases 1989;159(4):766‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/infdis/159.4.766', 'https://scholar.google.com/scholar_lookup?title=Comparative+efficacy+of+two,+three,+or+four+doses+of+TY21a+live+oral+typhoid+vaccine+in+enteric‐coated+capsules:+a+field+trial+in+an+endemic+area+&author=C+Ferreccio&author=MM+Levine&author=H+Rodriguez&author=R+Contreras&publication_year=1989&hl=en']",,https://doi.org/10.1093/infdis/159.4.766, Ferreccio 1989 {published data only}  ,excluded,CD001261-bbs2-0040, RCT compared different doses of the Ty21a vaccine 
CD001261-bib-0060,Hejfec LB. ,Results of the study of typhoid vaccines in four controlled field trials in the USSR, Bulletin of the World Health Organization ,1965,32,    ,['citation-journal'], Hejfec LB. Results of the study of typhoid vaccines in four controlled field trials in the USSR.  Bulletin of the World Health Organization 1965;32(1):1‐14. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Results+of+the+study+of+typhoid+vaccines+in+four+controlled+field+trials+in+the+USSR&author=LB+Hejfec&publication_year=1965&hl=en']",,, Hejfec 1965 {published data only}  ,excluded,CD001261-bbs2-0041," Two separate randomized trials, described together; none of the chemical subunit vaccines that were studied are in use  "
CD001261-bib-0061,"Khasanov MI, Kheifets LB, Salmin LV. ",A controlled field trial of the typhoid component of polyvalent enteric vaccine (NIISI polyvaccine), Bulletin of the World Health Organization ,1962,26,    ,['citation-journal']," Khasanov MI, Kheifets LB, Salmin LV. A controlled field trial of the typhoid component of polyvalent enteric vaccine (NIISI polyvaccine).  Bulletin of the World Health Organization 1962;26(3):371‐9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+controlled+field+trial+of+the+typhoid+component+of+polyvalent+enteric+vaccine+(NIISI+polyvaccine)+&author=MI+Khasanov&author=LB+Kheifets&author=LV+Salmin&publication_year=1962&hl=en']",,, Hejfec 1965 {published data only}  ,excluded,CD001261-bbs2-0041," Two separate randomized trials, described together; none of the chemical subunit vaccines that were studied are in use  "
CD001261-bib-0063,Hejfec LB. ,Results of the study of typhoid vaccines in four controlled field trials in the USSR, Bulletin of the World Health Organization ,1965,32,    ,['citation-journal'], Hejfec LB. Results of the study of typhoid vaccines in four controlled field trials in the USSR.  Bulletin of the World Health Organization 1965;32(1):1‐14. CENTRAL    Google Scholar     ,"['', 'https://scholar.google.com/scholar_lookup?title=Results+of+the+study+of+typhoid+vaccines+in+four+controlled+field+trials+in+the+USSR&author=LB+Hejfec&publication_year=1965&hl=en']",,, Hejfec 1966 {published data only}  ,excluded,CD001261-bbs2-0042," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0062,"Hejfec LB, Salmin LV, Lejtman MZ, Kuz'minova ML, Vasil'eva AV, Levina LA, et al. ",A controlled field trial and laboratory study of five typhoid vaccines in the USSR, Bulletin of the World Health Organization ,1966,34,    ,['citation-journal']," Hejfec LB, Salmin LV, Lejtman MZ, Kuz'minova ML, Vasil'eva AV, Levina LA, et al. A controlled field trial and laboratory study of five typhoid vaccines in the USSR.  Bulletin of the World Health Organization 1966;34(3):321‐39. CENTRAL    Google Scholar     ","['', ""https://scholar.google.com/scholar_lookup?title=A+controlled+field+trial+and+laboratory+study+of+five+typhoid+vaccines+in+the+USSR&author=LB+Hejfec&author=LV+Salmin&author=MZ+Lejtman&author=ML+Kuz'minova&author=AV+Vasil'eva&author=LA+Levina&publication_year=1966&hl=en""]",,, Hejfec 1966 {published data only}  ,excluded,CD001261-bbs2-0042," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0064,"Hejfec LB, Levina LA, Kuz'minova ML, Salmin LV, Slavina AM, Vasil'eva AV. ",Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine, Bulletin of the World Health Organization ,1968,38,    ,['citation-journal']," Hejfec LB, Levina LA, Kuz'minova ML, Salmin LV, Slavina AM, Vasil'eva AV. Controlled field trials of paratyphoid B vaccine and evaluation of the effectiveness of a single administration of typhoid vaccine.  Bulletin of the World Health Organization 1968;38(6):907‐15. CENTRAL    Google Scholar     ","['', ""https://scholar.google.com/scholar_lookup?title=Controlled+field+trials+of+paratyphoid+B+vaccine+and+evaluation+of+the+effectiveness+of+a+single+administration+of+typhoid+vaccine+&author=LB+Hejfec&author=LA+Levina&author=ML+Kuz'minova&author=LV+Salmin&author=AM+Slavina&author=AV+Vasil'eva&publication_year=1968&hl=en""]",,, Hejfec 1968 {published data only}  ,excluded,CD001261-bbs2-0043," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0065,"Hejfec LB, Levina LA, Kuz'minova ML, Slavina AM, Drozd AK, Tonojan IA, et al. ",A controlled field trial to evaluate the protective capacity of a single dose of acetone‐killed agar‐grown and heat‐killed broth‐grown typhoid vaccines, Bulletin of the World Health Organization ,1969,40,    ,['citation-journal']," Hejfec LB, Levina LA, Kuz'minova ML, Slavina AM, Drozd AK, Tonojan IA, et al. A controlled field trial to evaluate the protective capacity of a single dose of acetone‐killed agar‐grown and heat‐killed broth‐grown typhoid vaccines.  Bulletin of the World Health Organization 1969;40(6):903‐7. CENTRAL    Google Scholar     ","['', ""https://scholar.google.com/scholar_lookup?title=A+controlled+field+trial+to+evaluate+the+protective+capacity+of+a+single+dose+of+acetone‐killed+agar‐grown+and+heat‐killed+broth‐grown+typhoid+vaccines+&author=LB+Hejfec&author=LA+Levina&author=ML+Kuz'minova&author=AM+Slavina&author=AK+Drozd&author=IA+Tonojan&publication_year=1969&hl=en""]",,, Hejfec 1969 {published data only}  ,excluded,CD001261-bbs2-0044," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0066,"Hejfec LB, Levina LA, Salmin LB, Antonova AA, Segal LS, Kuzminova ML, et al. ","Controlled field trials of killed oral typhoid and paratyphoid B vaccines and cell‐free, chemical aerosol typhoid vaccine", Developments in Biological Standardization ,1976,33,    ,['citation-journal']," Hejfec LB, Levina LA, Salmin LB, Antonova AA, Segal LS, Kuzminova ML, et al. Controlled field trials of killed oral typhoid and paratyphoid B vaccines and cell‐free, chemical aerosol typhoid vaccine.  Developments in Biological Standardization 1976;33:93‐7. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Controlled+field+trials+of+killed+oral+typhoid+and+paratyphoid+B+vaccines+and+cell‐free,+chemical+aerosol+typhoid+vaccine+&author=LB+Hejfec&author=LA+Levina&author=LB+Salmin&author=AA+Antonova&author=LS+Segal&author=ML+Kuzminova&publication_year=1976&hl=en']",,, Hejfec 1976 {published data only}  ,excluded,CD001261-bbs2-0045," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0067,"Hien TT, Dung NT, Truong NT, Van NTT, Chau TNB, Van Hoang NM, et al. ",A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children, PLOS ONE ,2010,5,    ,['citation-journal']," Hien TT, Dung NT, Truong NT, Van NTT, Chau TNB, Van Hoang NM, et al. A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children.  PLOS ONE 2010;5(7):e11778. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0011778', 'https://scholar.google.com/scholar_lookup?title=A+randomised+trial+evaluating+the+safety+and+immunogenicity+of+the+novel+single+oral+dose+typhoid+vaccine+M01ZH09+in+healthy+Vietnamese+children+&author=TT+Hien&author=NT+Dung&author=NT+Truong&author=NTT+Van&author=TNB+Chau&author=NM+Hoang&publication_year=2010&hl=en']",,https://doi.org/10.1371/journal.pone.0011778, Hien 2010 {published data only}  ,excluded,CD001261-bbs2-0046," Evaluated adverse events of new M01ZH09 vaccine, no efficacy trials of this vaccine "
CD001261-bib-0068,"Hohmann EL, Oletta CA, Killeen KP, Miller SI. ",phoP/phoQ‐deleted Salmonella typhi (Ty800) is a safe and immunogenic single‐dose typhoid fever vaccine in volunteers, Journal of Infectious Diseases ,1996,173,    ,['citation-journal']," Hohmann EL, Oletta CA, Killeen KP, Miller SI. phoP/phoQ‐deleted Salmonella typhi (Ty800) is a safe and immunogenic single‐dose typhoid fever vaccine in volunteers.  Journal of Infectious Diseases 1996;173(6):1408‐14. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/infdis/173.6.1408', 'https://scholar.google.com/scholar_lookup?title=phoP/phoQ‐deleted+Salmonella+typhi+(Ty800)+is+a+safe+and+immunogenic+single‐dose+typhoid+fever+vaccine+in+volunteers+&author=EL+Hohmann&author=CA+Oletta&author=KP+Killeen&author=SI+Miller&publication_year=1996&hl=en']",,https://doi.org/10.1093/infdis/173.6.1408, Hohmann 1996a {published data only}  ,excluded,CD001261-bbs2-0047, No random allocation 
CD001261-bib-0069,"Hohmann EL, Oletta CA, Miller SI. ","Evaluation of a phoP/phoQ‐deleted, aroA‐deleted live oral Salmonella typhi vaccine strain in human volunteers", Vaccine ,1996,14,    ,['citation-journal']," Hohmann EL, Oletta CA, Miller SI. Evaluation of a phoP/phoQ‐deleted, aroA‐deleted live oral Salmonella typhi vaccine strain in human volunteers.  Vaccine 1996;14(1):19‐24. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0264-410X(95)00173-X', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+a+phoP/phoQ‐deleted,+aroA‐deleted+live+oral+Salmonella+typhi+vaccine+strain+in+human+volunteers+&author=EL+Hohmann&author=CA+Oletta&author=SI+Miller&publication_year=1996&hl=en']",,https://doi.org/10.1016/0264-410X(95)00173-X, Hohmann 1996b {published data only}  ,excluded,CD001261-bbs2-0048, No random allocation 
CD001261-bib-0070,EUCTR 2011‐003653‐26‐GB. ,Understanding immunity after typhoid vaccination,,,,   ,['citation-other']," EUCTR 2011‐003653‐26‐GB. Understanding immunity after typhoid vaccination [A phase II, single‐centre, randomised, single‐blind, study to evaluate Vi‐CRM197 against historical unvaccinated controls in a healthy adult challenge model, with a Vi‐PS vaccine control arm.]. clinicaltrialsregister.eu/ctr‐search/trial/2011‐003653‐26/GB EUCTR Identifier: (first received 12 December 2011). CENTRAL    ",[''],,, House 2011 {unpublished data only}  ,excluded,CD001261-bbs2-0049, Vi‐CRM197 human challenge study. Published protocol and note on register that ended prematurely  
CD001261-bib-0071,"Jin C, Gibani MM, Moore M, Juel HB, Jones E, Meiring J, et al. ","Efficacy and immunogenicity of a Vi‐tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial", Lancet ,2017,390,    ,['citation-journal']," Jin C, Gibani MM, Moore M, Juel HB, Jones E, Meiring J, et al. Efficacy and immunogenicity of a Vi‐tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.  Lancet 2017;390(10111):2472‐80. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(17)32149-9', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+immunogenicity+of+a+Vi‐tetanus+toxoid+conjugate+vaccine+in+the+prevention+of+typhoid+fever+using+a+controlled+human+infection+model+of+Salmonella+Typhi:+a+randomised+controlled,+phase+2b+trial+&author=C+Jin&author=MM+Gibani&author=M+Moore&author=HB+Juel&author=E+Jones&author=J+Meiring&publication_year=2017&hl=en']",,https://doi.org/10.1016/S0140-6736(17)32149-9, Jin 2017 {published data only}  ,excluded,CD001261-bbs2-0050, Vi‐TT (Typbar‐TCV) ‐ human challenge study ‐ excluded 
CD001261-bib-0072,"Juel HB, Thomaides‐Brears HB, Darton T, Jones C, Jones E, Shrestha S, et al. ",Salmonella Typhi bactericidal antibodies reduce disease severity but do not protect against typhoid fever in a controlled human infection model, Frontiers in Immunology ,2017,8,    ,['citation-journal']," Juel HB, Thomaides‐Brears HB, Darton T, Jones C, Jones E, Shrestha S, et al. Salmonella Typhi bactericidal antibodies reduce disease severity but do not protect against typhoid fever in a controlled human infection model.  Frontiers in Immunology 2017;8:1916. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Salmonella+Typhi+bactericidal+antibodies+reduce+disease+severity+but+do+not+protect+against+typhoid+fever+in+a+controlled+human+infection+model+&author=HB+Juel&author=HB+Thomaides‐Brears&author=T+Darton&author=C+Jones&author=E+Jones&author=S+Shrestha&publication_year=2017&hl=en']",,, Juel 2018 {published data only}  ,excluded,CD001261-bbs2-0051, Additional information on Darton 2016 – excluded as human challenge study  
CD001261-bib-0073,"Kantele A, Pakkanen SH, Karttunen R, Kantele JM. ",Head‐to‐head comparison of humoral immune responses to Vi capsular polysaccharide and salmonella typhi Ty21a typhoid vaccine—a randomised trial, PLOS ONE ,2013,8,    ,['citation-journal']," Kantele A, Pakkanen SH, Karttunen R, Kantele JM. Head‐to‐head comparison of humoral immune responses to Vi capsular polysaccharide and salmonella typhi Ty21a typhoid vaccine—a randomised trial.  PLOS ONE 2013;8(4):e60583. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0060583', 'https://scholar.google.com/scholar_lookup?title=Head‐to‐head+comparison+of+humoral+immune+responses+to+Vi+capsular+polysaccharide+and+salmonella+typhi+Ty21a+typhoid+vaccine—a+randomised+trial+&author=A+Kantele&author=SH+Pakkanen&author=R+Karttunen&author=JM+Kantele&publication_year=2013&hl=en']",,https://doi.org/10.1371/journal.pone.0060583, Kantele 2013 {published data only}  ,excluded,CD001261-bbs2-0052, No relevant outcome measures 
CD001261-bib-0074,"Keddy KH, Klugman KP, Hansford CF, Blondeau C, Bouveret le Cam NN. ",Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization, Vaccine ,1999,17,    ,['citation-journal']," Keddy KH, Klugman KP, Hansford CF, Blondeau C, Bouveret le Cam NN. Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization.  Vaccine 1999;17(2):110‐3. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0264-410X(98)00160-1', 'https://scholar.google.com/scholar_lookup?title=Persistence+of+antibodies+to+the+Salmonella+typhi+Vi+capsular+polysaccharide+vaccine+in+South+African+school+children+ten+years+after+immunization+&author=KH+Keddy&author=KP+Klugman&author=CF+Hansford&author=C+Blondeau&author=NN+BouveretleCam&publication_year=1999&hl=en']",,https://doi.org/10.1016/S0264-410X(98)00160-1, Keddy 1999 {published data only}  ,excluded,CD001261-bbs2-0053, No relevant outcome measures 
CD001261-bib-0075,"Khan S, Chatfield S, Stratford R, Bedwell J, Bentely M, Sulsh S, et al. ",Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans, Vaccine ,2007,25,    ,['citation-journal']," Khan S, Chatfield S, Stratford R, Bedwell J, Bentely M, Sulsh S, et al. Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans.  Vaccine 2007;25(21):4175‐82. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.vaccine.2007.03.007', 'https://scholar.google.com/scholar_lookup?title=Ability+of+SPI2+mutant+of+S.+typhi+to+effectively+induce+antibody+responses+to+the+mucosal+antigen+enterotoxigenic+E.+coli+heat+labile+toxin+B+subunit+after+oral+delivery+to+humans+&author=S+Khan&author=S+Chatfield&author=R+Stratford&author=J+Bedwell&author=M+Bentely&author=S+Sulsh&publication_year=2007&hl=en']",,https://doi.org/10.1016/j.vaccine.2007.03.007, Khan 2007 {published data only}  ,excluded,CD001261-bbs2-0054, Non‐randomized study 
CD001261-bib-0076,"Khoo SH, St Clair Roberts J, Mandal BK. ",Safety and efficacy of combined meningococcal and typhoid vaccine, BMJ ,1995,310,    ,['citation-journal']," Khoo SH, St Clair Roberts J, Mandal BK. Safety and efficacy of combined meningococcal and typhoid vaccine.  BMJ 1995;310(6984):908‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1136/bmj.310.6984.908', 'https://scholar.google.com/scholar_lookup?title=Safety+and+efficacy+of+combined+meningococcal+and+typhoid+vaccine&author=SH+Khoo&author=J+ClairRoberts&author=BK+Mandal&publication_year=1995&hl=en']",,https://doi.org/10.1136/bmj.310.6984.908, Khoo 1995 {published data only}  ,excluded,CD001261-bbs2-0055, Evaluated safety of Vi vaccine compared with meningococcal vaccine or combination 
CD001261-bib-0077,"Kirkpatrick B, McKenzie R, O'Neill J, Larsson C, Bourgeois A, Shimko J, et al. ","Evaluation of Salmonella enterica serovar Typhi (Ty2 aroCssaV) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers", Vaccine ,2006,24,    ,['citation-journal']," Kirkpatrick B, McKenzie R, O'Neill J, Larsson C, Bourgeois A, Shimko J, et al. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroCssaV) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.  Vaccine 2006;24(2):116‐23. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.vaccine.2005.08.008', ""https://scholar.google.com/scholar_lookup?title=Evaluation+of+Salmonella+enterica+serovar+Typhi+(Ty2+aroCssaV)+M01ZH09,+with+a+defined+mutation+in+the+Salmonella+pathogenicity+island+2,+as+a+live,+oral+typhoid+vaccine+in+human+volunteers+&author=B+Kirkpatrick&author=R+McKenzie&author=J+O'Neill&author=C+Larsson&author=A+Bourgeois&author=J+Shimko&publication_year=2006&hl=en""]",,https://doi.org/10.1016/j.vaccine.2005.08.008, Kirkpatrick 2006 {published data only}  ,excluded,CD001261-bbs2-0056, Evaluated adverse events of new M01ZH09 vaccine; no efficacy trials of this vaccine 
CD001261-bib-0078,Lebacq E. ,"Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12‐month and 0, 24‐month administration", BioDrugs ,2001,15,    ,['citation-journal']," Lebacq E. Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12‐month and 0, 24‐month administration.  BioDrugs 2001;15(Suppl 1):5‐12. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2165/00063030-200115001-00002', 'https://scholar.google.com/scholar_lookup?title=Comparative+tolerability+and+immunogenicity+of+Typherix+or+Typhim+Vi+in+healthy+adults:+0,+12‐month+and+0,+24‐month+administration+&author=E+Lebacq&publication_year=2001&hl=en']",,https://doi.org/10.2165/00063030-200115001-00002, Lebacq 2001 {published data only}  ,excluded,CD001261-bbs2-0057, Evaluated different brands of Vi vaccine 
CD001261-bib-0079,"Levin DM, Wong KH, Reynolds HY, Sutton A, Northrup RS. ",Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans, Infection and Immunity ,1975,12,    ,['citation-journal']," Levin DM, Wong KH, Reynolds HY, Sutton A, Northrup RS. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.  Infection and Immunity 1975;12(6):1290‐4. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/iai.12.6.1290-1294.1975', 'https://scholar.google.com/scholar_lookup?title=Vi+antigen+from+Salmonella+typhosa+and+immunity+against+typhoid+fever.+11.+Safety+and+antigenicity+in+humans+&author=DM+Levin&author=KH+Wong&author=HY+Reynolds&author=A+Sutton&author=RS+Northrup&publication_year=1975&hl=en']",,https://doi.org/10.1128/iai.12.6.1290-1294.1975, Levin 1975 {published data only}  ,excluded,CD001261-bbs2-0058," No random allocation; compared Vi with inactivated whole‐cell vaccine, which is no longer in use  "
CD001261-bib-0080,"Lyon CE, Sadigh KS, Carmolli MP, Harro C, Sheldon E, Lindow JC, et al. ","In a randomized, double‐blinded, placebo‐controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 × 10(10) colony‐forming units", Vaccine ,2010,28,    ,['citation-journal']," Lyon CE, Sadigh KS, Carmolli MP, Harro C, Sheldon E, Lindow JC, et al. In a randomized, double‐blinded, placebo‐controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 × 10(10) colony‐forming units.  Vaccine 2010;28(20):3602‐8. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.vaccine.2010.02.017', 'https://scholar.google.com/scholar_lookup?title=In+a+randomized,+double‐blinded,+placebo‐controlled+trial,+the+single+oral+dose+typhoid+vaccine,+M01ZH09,+is+safe+and+immunogenic+at+doses+up+to+1.7+×+10(10)+colony‐forming+units+&author=CE+Lyon&author=KS+Sadigh&author=MP+Carmolli&author=C+Harro&author=E+Sheldon&author=JC+Lindow&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.vaccine.2010.02.017, Lyon 2010 {published data only}  ,excluded,CD001261-bbs2-0059, Evaluated adverse events of new M01ZH09 vaccine; no efficacy trials of this vaccine 
CD001261-bib-0081,"Meiring JE, Gibani M. ","The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26‐27 October 2016, Oxford, UK", Vaccine ,2017,35,    ,['citation-journal']," Meiring JE, Gibani M. The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26‐27 October 2016, Oxford, UK.  Vaccine 2017;35(38):5081‐8. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+Typhoid+Vaccine+Acceleration+Consortium+(TyVAC):+Vaccine+effectiveness+study+designs:+Accelerating+the+introduction+of+typhoid+conjugate+vaccines+and+reducing+the+global+burden+of+enteric+fever.+Report+from+a+meeting+held+on+26‐27+October+2016,+Oxford,+UK+&author=JE+Meiring&author=M+Gibani&publication_year=2017&hl=en']",,, Meiring 2017 {published data only}  ,excluded,CD001261-bbs2-0060, Review article ‐ no new trials referenced 
CD001261-bib-0082,"Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM. ","Safety and immunogenicity of a Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar‐TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2‐cohort, open‐label, double‐blind, randomized controlled phase 3 study", Clinical Infectious Diseases ,2015,61,    ,['citation-journal']," Mohan VK, Varanasi V, Singh A, Pasetti MF, Levine MM, Venkatesan R, Ella KM. Safety and immunogenicity of a Vi polysaccharide–tetanus toxoid conjugate vaccine (Typbar‐TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2‐cohort, open‐label, double‐blind, randomized controlled phase 3 study.  Clinical Infectious Diseases 2015;61(3):393‐402. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+a+Vi+polysaccharide–tetanus+toxoid+conjugate+vaccine+(Typbar‐TCV)+in+healthy+infants,+children,+and+adults+in+typhoid+endemic+areas:+a+multicenter,+2‐cohort,+open‐label,+double‐blind,+randomized+controlled+phase+3+study+&author=VK+Mohan&author=V+Varanasi&author=A+Singh&author=MF+Pasetti&author=MM+Levine&author=R+Venkatesan&author=KM+Ella&publication_year=2015&hl=en']",,, Mohan 2015 {published data only}  ,excluded,CD001261-bbs2-0061, No efficacy data for Typbar TCV yet so excluded as per protocol as must have efficacy data available for vaccine for adverse effects to be included in review  
CD001261-bib-0083,"Murphy JR, Grez L, Schlesinger L, Ferreccio C, Baqar S, Munoz C, et al. ",Salmonella typhi Ty21a vaccine for young children, Infection and Immunity ,1991,59,    ,['citation-journal']," Murphy JR, Grez L, Schlesinger L, Ferreccio C, Baqar S, Munoz C, et al. Salmonella typhi Ty21a vaccine for young children.  Infection and Immunity 1991;59(11):4291‐3. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/iai.59.11.4291-4293.1991', 'https://scholar.google.com/scholar_lookup?title=Salmonella+typhi+Ty21a+vaccine+for+young+children&author=JR+Murphy&author=L+Grez&author=L+Schlesinger&author=C+Ferreccio&author=S+Baqar&author=C+Munoz&publication_year=1991&hl=en']",,https://doi.org/10.1128/iai.59.11.4291-4293.1991, Murphy 1991 {published data only}  ,excluded,CD001261-bbs2-0062, No random allocation to vaccine and placebo arms 
CD001261-bib-0084,"Nisini R, Biselli R, Matricardi PM, Fattorossi A, D'Amelio R. ",Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits, Vaccine ,1993,11,    ,['citation-journal']," Nisini R, Biselli R, Matricardi PM, Fattorossi A, D'Amelio R. Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits.  Vaccine 1993;11(5):582‐6. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/0264-410X(93)90237-R', ""https://scholar.google.com/scholar_lookup?title=Clinical+and+immunological+response+to+typhoid+vaccination+with+parenteral+or+oral+vaccines+in+two+groups+of+30+recruits+&author=R+Nisini&author=R+Biselli&author=PM+Matricardi&author=A+Fattorossi&author=R+D'Amelio&publication_year=1993&hl=en""]",,https://doi.org/10.1016/0264-410X(93)90237-R, Nisini 1993 {published data only}  ,excluded,CD001261-bbs2-0063, No random allocation 
CD001261-bib-0085,"Ochiai RL, Khan MI, Soofi SB, Sur D, Kanungo S, You YA, et al. ","Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India", Clinical and Vaccine Immunology ,2014,21,    ,['citation-journal']," Ochiai RL, Khan MI, Soofi SB, Sur D, Kanungo S, You YA, et al. Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India.  Clinical and Vaccine Immunology 2014;21(5):661‐6. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/CVI.00791-13', 'https://scholar.google.com/scholar_lookup?title=Immune+responses+to+Vi+capsular+polysaccharide+typhoid+vaccine+in+children+2+to+16+years+old+in+Karachi,+Pakistan,+and+Kolkata,+India+&author=RL+Ochiai&author=MI+Khan&author=SB+Soofi&author=D+Sur&author=S+Kanungo&author=YA+You&publication_year=2014&hl=en']",,https://doi.org/10.1128/CVI.00791-13, Ochiai 2014 {published data only}  ,excluded,CD001261-bbs2-0064, No efficacy or adverse effects/safety outcomes 
CD001261-bib-0086,"Panchanathan V, Kumar S, Yeap W, Devi S, Ismail R, Sarijan S, et al. ",Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole‐cell killed vaccine in Malaysian Air Force recruits, Bulletin of the World Health Organization ,2001,79,    ,['citation-journal']," Panchanathan V, Kumar S, Yeap W, Devi S, Ismail R, Sarijan S, et al. Comparison of safety and immunogenicity of a Vi polysaccharide typhoid vaccine with a whole‐cell killed vaccine in Malaysian Air Force recruits.  Bulletin of the World Health Organization 2001;79(9):811‐7. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+safety+and+immunogenicity+of+a+Vi+polysaccharide+typhoid+vaccine+with+a+whole‐cell+killed+vaccine+in+Malaysian+Air+Force+recruits+&author=V+Panchanathan&author=S+Kumar&author=W+Yeap&author=S+Devi&author=R+Ismail&author=S+Sarijan&publication_year=2001&hl=en']",,, Panchanathan 2001 {published data only}  ,excluded,CD001261-bbs2-0065," Compared Vi vaccine with inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0087,Polish Typhoid Committee. ,"Controlled field trials and laboratory studies on the effectiveness of typhoid vaccines in Poland, 1961‐64", Bulletin of the World Health Organization ,1966,34,   ,['citation-journal']," Polish Typhoid Committee. Controlled field trials and laboratory studies on the effectiveness of typhoid vaccines in Poland, 1961‐64.  Bulletin of the World Health Organization 1966;34(2):211‐22. CENTRAL    ",[''],,, Polish committee 1966 {published data only}  ,excluded,CD001261-bbs2-0066," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0088,"Sabitha P, Prabha Adhikari MR, Chowdary A, Prabhu M, Soofi M, Shetty M, et al. ",Comparison of the immunogenicity and safety of two different brands of Salmonella typhi Vi capsular polysaccharide vaccine, Indian Journal of Medical Sciences ,2004,58,    ,['citation-journal']," Sabitha P, Prabha Adhikari MR, Chowdary A, Prabhu M, Soofi M, Shetty M, et al. Comparison of the immunogenicity and safety of two different brands of Salmonella typhi Vi capsular polysaccharide vaccine.  Indian Journal of Medical Sciences 2004;58(4):141‐9. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+the+immunogenicity+and+safety+of+two+different+brands+of+Salmonella+typhi+Vi+capsular+polysaccharide+vaccine+&author=P+Sabitha&author=MR+PrabhaAdhikari&author=A+Chowdary&author=M+Prabhu&author=M+Soofi&author=M+Shetty&publication_year=2004&hl=en']",,, Sabitha 2004 {published data only}  ,excluded,CD001261-bbs2-0067, Compared 2 brands of Vi vaccine 
CD001261-bib-0089,"Tacket CO, Hone DM, Curtiss R, Kelly SM, Losonsky G, Guers L, et al. ",Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers, Infection and Immunity ,1992,60,    ,['citation-journal']," Tacket CO, Hone DM, Curtiss R, Kelly SM, Losonsky G, Guers L, et al. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.  Infection and Immunity 1992;60(2):536‐41. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/iai.60.2.536-541.1992', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+the+safety+and+immunogenicity+of+delta+aroC+delta+aroD+and+delta+cya+delta+crp+Salmonella+typhi+strains+in+adult+volunteers+&author=CO+Tacket&author=DM+Hone&author=R+Curtiss&author=SM+Kelly&author=G+Losonsky&author=L+Guers&publication_year=1992&hl=en']",,https://doi.org/10.1128/iai.60.2.536-541.1992, Tacket 1992 {published data only}  ,excluded,CD001261-bbs2-0068, Evaluated experimental live‐attenuated oral vaccine candidates; no efficacy trials of these vaccines  
CD001261-bib-0090,"Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Nataro JP, Edelman R, et al. ",Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans, Infection and Immunity ,1997,65,    ,['citation-journal']," Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Nataro JP, Edelman R, et al. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.  Infection and Immunity 1997;65(2):452‐6. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/iai.65.2.452-456.1997', 'https://scholar.google.com/scholar_lookup?title=Safety+of+live+oral+Salmonella+typhi+vaccine+strains+with+deletions+in+htrA+and+aroC+aroD+and+immune+response+in+humans+&author=CO+Tacket&author=MB+Sztein&author=GA+Losonsky&author=SS+Wasserman&author=JP+Nataro&author=R+Edelman&publication_year=1997&hl=en']",,https://doi.org/10.1128/iai.65.2.452-456.1997, Tacket 1997 {published data only}  ,excluded,CD001261-bbs2-0069, Evaluated experimental live‐attenuated oral vaccine candidates; no efficacy trials of these vaccines  
CD001261-bib-0091,"Tacket CO, Sztein MB, Wasserman SS, Losonsky G, Kotloff KL, Wyant TL, et al. ",Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908‐htrA in U.S. volunteers, Infection and immunity ,2000,68,    ,['citation-journal']," Tacket CO, Sztein MB, Wasserman SS, Losonsky G, Kotloff KL, Wyant TL, et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908‐htrA in U.S. volunteers.  Infection and immunity 2000;68(3):1196‐201. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/IAI.68.3.1196-1201.2000', 'https://scholar.google.com/scholar_lookup?title=Phase+2+clinical+trial+of+attenuated+Salmonella+enterica+serovar+typhi+oral+live+vector+vaccine+CVD+908‐htrA+in+U.S.+volunteers+&author=CO+Tacket&author=MB+Sztein&author=SS+Wasserman&author=G+Losonsky&author=KL+Kotloff&author=TL+Wyant&publication_year=2000&hl=en']",,https://doi.org/10.1128/IAI.68.3.1196-1201.2000, Tacket 2000 {published data only}  ,excluded,CD001261-bbs2-0070, Evaluated experimental live‐attenuated oral vaccine candidates; no efficacy trials of these vaccines  
CD001261-bib-0092,"Tapa S, Cvjetanovic B. ",Controlled field trial on the effectiveness of one and two doses of acetone‐inactivated and dried vaccine, Bulletin of the World Health Organization ,1975,52,    ,['citation-journal']," Tapa S, Cvjetanovic B. Controlled field trial on the effectiveness of one and two doses of acetone‐inactivated and dried vaccine.  Bulletin of the World Health Organization 1975;52(1):75‐80. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Controlled+field+trial+on+the+effectiveness+of+one+and+two+doses+of+acetone‐inactivated+and+dried+vaccine+&author=S+Tapa&author=B+Cvjetanovic&publication_year=1975&hl=en']",,, Tapa 1975 {published data only}  ,excluded,CD001261-bbs2-0071," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0093,"Thiem VD, Danovaro‐Holliday MC, Canh do G, Son ND, Hoa NT, Thuy DT, et al. ","The feasibility of a school‐based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy", Southeast Asian Journal of Tropical Medicine and Public Health ,2006,37,    ,['citation-journal']," Thiem VD, Danovaro‐Holliday MC, Canh do G, Son ND, Hoa NT, Thuy DT, et al. The feasibility of a school‐based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy.  Southeast Asian Journal of Tropical Medicine and Public Health 2006;37(3):515‐22. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=The+feasibility+of+a+school‐based+VI+polysaccharide+vaccine+mass+immunization+campaign+in+Hue+City,+central+Vietnam:+streamlining+a+typhoid+fever+preventive+strategy+&author=VD+Thiem&author=MC+Danovaro‐Holliday&author=G+Canhdo&author=ND+Son&author=NT+Hoa&author=DT+Thuy&publication_year=2006&hl=en']",,, Thiem 2006 {published data only}  ,excluded,CD001261-bbs2-0072, No relevant outcome measures 
CD001261-bib-0094,"Thiem VD, Lin FY, Son NH, Anh DD, Mao ND, Chu C. ","The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti‐Vi, and is compatible with routine infant vaccines", Clinical and Vaccine Immunology ,2011,18,    ,['citation-journal']," Thiem VD, Lin FY, Son NH, Anh DD, Mao ND, Chu C. The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti‐Vi, and is compatible with routine infant vaccines.  Clinical and Vaccine Immunology 2011;18(5):730‐5. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1128/CVI.00532-10', 'https://scholar.google.com/scholar_lookup?title=The+Vi+conjugate+typhoid+vaccine+is+safe,+elicits+protective+levels+of+IgG+anti‐Vi,+and+is+compatible+with+routine+infant+vaccines+&author=VD+Thiem&author=FY+Lin&author=NH+Son&author=DD+Anh&author=ND+Mao&author=C+Chu&publication_year=2011&hl=en']",,https://doi.org/10.1128/CVI.00532-10, Thiem 2011 {published data only}  ,excluded,CD001261-bbs2-0073, Adverse event only trial and placebo not used for comparison (Hibb vaccine used as comparison)  
CD001261-bib-0095,"van Damme P, Kafeja F, Anemona A, Basile V, Hilbert AK, De Coster I, et al. ","Safety, immunogenicity and dose ranging of a new Vi‐CRM(1)(9)(7) conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults", PLOS ONE ,2011,6,    ,['citation-journal']," van Damme P, Kafeja F, Anemona A, Basile V, Hilbert AK, De Coster I, et al. Safety, immunogenicity and dose ranging of a new Vi‐CRM(1)(9)(7) conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults.  PLOS ONE 2011;6(9):e25398. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0025398', 'https://scholar.google.com/scholar_lookup?title=Safety,+immunogenicity+and+dose+ranging+of+a+new+Vi‐CRM(1)(9)(7)+conjugate+vaccine+against+typhoid+fever:+randomized+clinical+testing+in+healthy+adults+&author=P+Damme&author=F+Kafeja&author=A+Anemona&author=V+Basile&author=AK+Hilbert&author=I+Coster&publication_year=2011&hl=en']",,https://doi.org/10.1371/journal.pone.0025398, van Damme 2011 {published data only}  ,excluded,CD001261-bbs2-0074, Evaluated adverse events of new conjugate vaccine (Vi‐CRM); no efficacy trials of this vaccine  
CD001261-bib-0096,"Voysey M, Pollard AJ. ",Sero‐efficacy of Vi‐polysaccharide tetanus‐toxoid typhoid conjugate vaccine (Typbar‐TCV),,,,   ,['citation-other']," Voysey M, Pollard AJ. Sero‐efficacy of Vi‐polysaccharide tetanus‐toxoid typhoid conjugate vaccine (Typbar‐TCV). Clinical Infectious Diseases 2018 Jan 17 [Epub ahead of print]. [DOI: 10.1093/cid/cix1145]CENTRAL    ",[''],,, Voysey 2018 {published data only}  ,excluded,CD001261-bbs2-0075," Additional data for Mohan 2015 ‐ Vi‐TT (Typbar‐TCV) ‐ no efficacy data, immunological data  "
CD001261-bib-0097,"Wahdan MH, Sippel JE, Mikhail IA, Rahka AE, Anderson ES, Sparks HA, et al. ",Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella typhi Ty2, Bulletin of the World Health Organization ,1975,52,    ,['citation-journal']," Wahdan MH, Sippel JE, Mikhail IA, Rahka AE, Anderson ES, Sparks HA, et al. Controlled field trial of a typhoid vaccine prepared with a nonmotile mutant of Salmonella typhi Ty2.  Bulletin of the World Health Organization 1975;52(1):69‐73. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Controlled+field+trial+of+a+typhoid+vaccine+prepared+with+a+nonmotile+mutant+of+Salmonella+typhi+Ty2+&author=MH+Wahdan&author=JE+Sippel&author=IA+Mikhail&author=AE+Rahka&author=ES+Anderson&author=HA+Sparks&publication_year=1975&hl=en']",,, Wahdan 1975 {published data only}  ,excluded,CD001261-bbs2-0076," Quasi‐RCT evaluating the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0098,"Wahid R, Pasetti MF, Maciel M, Simon JK, Tacket CO, Levine MM, et al. ",Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD‐S. Typhi‐specific IgA and IgG B memory cells in humans, Clinical Immunology ,2011,138,    ,['citation-journal']," Wahid R, Pasetti MF, Maciel M, Simon JK, Tacket CO, Levine MM, et al. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD‐S. Typhi‐specific IgA and IgG B memory cells in humans.  Clinical Immunology 2011;138(2):187‐200. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.clim.2010.11.006', 'https://scholar.google.com/scholar_lookup?title=Oral+priming+with+Salmonella+Typhi+vaccine+strain+CVD+909+followed+by+parenteral+boost+with+the+S.+Typhi+Vi+capsular+polysaccharide+vaccine+induces+CD27+IgD‐S.+Typhi‐specific+IgA+and+IgG+B+memory+cells+in+humans+&author=R+Wahid&author=MF+Pasetti&author=M+Maciel&author=JK+Simon&author=CO+Tacket&author=MM+Levine&publication_year=2011&hl=en']",,https://doi.org/10.1016/j.clim.2010.11.006, Wahid 2011 {published data only}  ,excluded,CD001261-bbs2-0077, No relevant outcome measures 
CD001261-bib-0099,"Yang J, Acosta CJ, Si GA, Zeng J, Li CY, Liang DB, et al. ",A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in Southeast China: a cluster‐randomized trial, BMC Public Health ,2005,5,    ,['citation-journal']," Yang J, Acosta CJ, Si GA, Zeng J, Li CY, Liang DB, et al. A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in Southeast China: a cluster‐randomized trial.  BMC Public Health 2005;5(1):49. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2458-5-49', 'https://scholar.google.com/scholar_lookup?title=A+mass+vaccination+campaign+targeting+adults+and+children+to+prevent+typhoid+fever+in+Hechi;+expanding+the+use+of+Vi+polysaccharide+vaccine+in+Southeast+China:+a+cluster‐randomized+trial+&author=J+Yang&author=CJ+Acosta&author=GA+Si&author=J+Zeng&author=CY+Li&author=DB+Liang&publication_year=2005&hl=en']",,https://doi.org/10.1186/1471-2458-5-49, Yang 2005 {published data only}  ,excluded,CD001261-bbs2-0078, No relevant outcome measures 
CD001261-bib-0100,"Yang J, Ye Q, Dong BQ. ",Immediate adverse reaction after mass vaccination of groups A+C meningococcal polysaccharide vaccine, Chinese Journal of Biologicals ,2009,22,    ,['citation-journal']," Yang J, Ye Q, Dong BQ. Immediate adverse reaction after mass vaccination of groups A+C meningococcal polysaccharide vaccine.  Chinese Journal of Biologicals 2009;22(7):699‐701. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Immediate+adverse+reaction+after+mass+vaccination+of+groups+A+C+meningococcal+polysaccharide+vaccine+&author=J+Yang&author=Q+Ye&author=BQ+Dong&publication_year=2009&hl=en']",,, Yang 2009 {published data only}  ,excluded,CD001261-bbs2-0079," Safety only, evaluated different brands of same vaccine "
CD001261-bib-0101,Yugoslav Typhoid Commission. ,A controlled field trial of the effectiveness of phenol and alcohol typhoid vaccines: final report, Bulletin of the World Health Organization ,1962,26,   ,['citation-journal'], Yugoslav Typhoid Commission. A controlled field trial of the effectiveness of phenol and alcohol typhoid vaccines: final report.  Bulletin of the World Health Organization 1962;26(3):357‐69. CENTRAL    ,[''],,, Yug Ty Comm 1962 {published data only}  ,excluded,CD001261-bbs2-0080," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0102,Yugoslav Typhoid Commission. ,Field and laboratory studies with typhoid vaccines. A preliminary report, Bulletin of the World Health Organization ,1957,16,   ,['citation-journal'], Yugoslav Typhoid Commission. Field and laboratory studies with typhoid vaccines. A preliminary report.  Bulletin of the World Health Organization 1957;16(5):897‐910. CENTRAL    ,[''],,, Yug Ty Comm 1962 {published data only}  ,excluded,CD001261-bbs2-0080," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0103,Yugoslav Typhoid Commission. ,A controlled field trial of the effectiveness of acetone‐dried and inactivated and heat‐phenol‐inactivated typhoid vaccines in Yugoslavia, Bulletin of the World Health Organization ,1964,30,   ,['citation-journal'], Yugoslav Typhoid Commission. A controlled field trial of the effectiveness of acetone‐dried and inactivated and heat‐phenol‐inactivated typhoid vaccines in Yugoslavia.  Bulletin of the World Health Organization 1964;30(5):623‐30. CENTRAL    ,[''],,, Yug Ty Comm 1964 {published data only}  ,excluded,CD001261-bbs2-0081," Evaluated the inactivated whole‐cell vaccine, which is no longer in use "
CD001261-bib-0104,"Zhou W‐Z, Zeng M, Pan H‐X. ",Adverse reaction and immune effect of typhoid Vi polysaccharide vaccine, Chinese Journal of Biologicals ,2008,21,    ,['citation-journal']," Zhou W‐Z, Zeng M, Pan H‐X. Adverse reaction and immune effect of typhoid Vi polysaccharide vaccine.  Chinese Journal of Biologicals 2008;21(5):425‐7. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Adverse+reaction+and+immune+effect+of+typhoid+Vi+polysaccharide+vaccine&author=W‐Z+Zhou&author=M+Zeng&author=H‐X+Pan&publication_year=2008&hl=en']",,, Zhou 2008 CHN {published data only}  ,excluded,CD001261-bbs2-0082, Safety only; evaluated different brands of same vaccine 
CD001261-bib-0108,"Andrews JR, Ryan ET. ",Diagnostics for invasive Salmonella infections: current challenges and future directions, Vaccine ,2015,33,    ,['citation-journal']," Andrews JR, Ryan ET. Diagnostics for invasive Salmonella infections: current challenges and future directions.  Vaccine 2015;33(3):C8‐15.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.vaccine.2015.02.030', 'https://scholar.google.com/scholar_lookup?title=Diagnostics+for+invasive+Salmonella+infections:+current+challenges+and+future+directions&author=JR+Andrews&author=ET+Ryan&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.vaccine.2015.02.030, Andrews 2015 ,additional,CD001261-bbs2-0086,
CD001261-bib-0109,"Bhan MK, Bahl R, Bhatnagar S. ",Typhoid and paratyphoid fever, Lancet ,2005,366,    ,['citation-journal']," Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever.  Lancet 2005;366(9487):749‐62.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(05)67181-4', 'https://scholar.google.com/scholar_lookup?title=Typhoid+and+paratyphoid+fever&author=MK+Bhan&author=R+Bahl&author=S+Bhatnagar&publication_year=2005&hl=en']",,https://doi.org/10.1016/S0140-6736(05)67181-4, Bhan 2005 ,additional,CD001261-bbs2-0087,
CD001261-bib-0110,Bhutta ZA. ,Impact of age and drug resistance on mortality in typhoid fever, Archives of Diseases of Childhood ,1996,75,    ,['citation-journal'], Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever.  Archives of Diseases of Childhood 1996;75(3):214‐7.    Link to article     Google Scholar     ,"['https://doi.org/10.1136/adc.75.3.214', 'https://scholar.google.com/scholar_lookup?title=Impact+of+age+and+drug+resistance+on+mortality+in+typhoid+fever&author=ZA+Bhutta&publication_year=1996&hl=en']",,https://doi.org/10.1136/adc.75.3.214, Bhutta 1996 ,additional,CD001261-bbs2-0088,
CD001261-bib-0111,"Britto C, Pollard AJ, Voysey M, Blohmke CJ. ",An appraisal of the clinical features of pediatric enteric fever: systematic review and meta‐analysis of the age‐stratified disease occurrence, Clinical Infectious Diseases ,2017,64,    ,['citation-journal']," Britto C, Pollard AJ, Voysey M, Blohmke CJ. An appraisal of the clinical features of pediatric enteric fever: systematic review and meta‐analysis of the age‐stratified disease occurrence.  Clinical Infectious Diseases 2017;64(11):1604‐11.    Link to article     Google Scholar     ","['https://doi.org/10.1093/cid/cix229', 'https://scholar.google.com/scholar_lookup?title=An+appraisal+of+the+clinical+features+of+pediatric+enteric+fever:+systematic+review+and+meta‐analysis+of+the+age‐stratified+disease+occurrence+&author=C+Britto&author=AJ+Pollard&author=M+Voysey&author=CJ+Blohmke&publication_year=2017&hl=en']",,https://doi.org/10.1093/cid/cix229, Britto 2017 ,additional,CD001261-bbs2-0089,
CD001261-bib-0112,"Clemens J, Shin S, Ali M. ",New approaches to the assessment of vaccine herd protection in clinical trials, Lancet Infectious Diseases ,2011,11,    ,['citation-journal']," Clemens J, Shin S, Ali M. New approaches to the assessment of vaccine herd protection in clinical trials.  Lancet Infectious Diseases 2011;11(6):482‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S1473-3099(10)70318-2', 'https://scholar.google.com/scholar_lookup?title=New+approaches+to+the+assessment+of+vaccine+herd+protection+in+clinical+trials&author=J+Clemens&author=S+Shin&author=M+Ali&publication_year=2011&hl=en']",,https://doi.org/10.1016/S1473-3099(10)70318-2, Clemens 2011 ,additional,CD001261-bbs2-0090,
CD001261-bib-0113,"Crump JA, Luby SP, Mintz ED. ",The global burden of typhoid fever, Bulletin of the World Health Organization ,2004,82,    ,['citation-journal']," Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever.  Bulletin of the World Health Organization 2004;82(5):346‐53.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=The+global+burden+of+typhoid+fever&author=JA+Crump&author=SP+Luby&author=ED+Mintz&publication_year=2004&hl=en'],,, Crump 2004 ,additional,CD001261-bbs2-0091,
CD001261-bib-0114,Crump JA. ,Building the case for wider use of typhoid vaccines, Vaccine ,2015,33,    ,['citation-journal'], Crump JA. Building the case for wider use of typhoid vaccines.  Vaccine 2015;33(3):C1‐2.    Link to article     Google Scholar     ,"['https://doi.org/10.1016/j.vaccine.2015.04.033', 'https://scholar.google.com/scholar_lookup?title=Building+the+case+for+wider+use+of+typhoid+vaccines&author=JA+Crump&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.vaccine.2015.04.033, Crump 2015 ,additional,CD001261-bbs2-0092,
CD001261-bib-0115,"Date KA, Bentsi‐Enchill A, Marks F, Fox K. ",Typhoid fever vaccination strategies, Vaccine ,2015,33,    ,['citation-journal']," Date KA, Bentsi‐Enchill A, Marks F, Fox K. Typhoid fever vaccination strategies.  Vaccine 2015;33(3):C55‐61.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.vaccine.2015.04.028', 'https://scholar.google.com/scholar_lookup?title=Typhoid+fever+vaccination+strategies&author=KA+Date&author=A+Bentsi‐Enchill&author=F+Marks&author=K+Fox&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.vaccine.2015.04.028, Date 2015 ,additional,CD001261-bbs2-0093,
CD001261-bib-0116,"Deroeck D, Ochiai L, Yang J, Anh D, Alag V, Clemens J. ",Typhoid vaccination: the Asian experience, Expert Review of Vaccines ,2008,7,    ,['citation-journal']," Deroeck D, Ochiai L, Yang J, Anh D, Alag V, Clemens J. Typhoid vaccination: the Asian experience.  Expert Review of Vaccines 2008;7(5):547‐60.    Link to article     Google Scholar     ","['https://doi.org/10.1586/14760584.7.5.547', 'https://scholar.google.com/scholar_lookup?title=Typhoid+vaccination:+the+Asian+experience&author=D+Deroeck&author=L+Ochiai&author=J+Yang&author=D+Anh&author=V+Alag&author=J+Clemens&publication_year=2008&hl=en']",,https://doi.org/10.1586/14760584.7.5.547, DeRoeck 2008 ,additional,CD001261-bbs2-0094,
CD001261-bib-0117,"Garmory HS, Brown KA, Titball RW. ",Salmonella vaccines for use in humans: present and future perspectives, FEMS Microbiology Reviews ,2002,26,    ,['citation-journal']," Garmory HS, Brown KA, Titball RW. Salmonella vaccines for use in humans: present and future perspectives.  FEMS Microbiology Reviews 2002;26(4):339‐53.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Salmonella+vaccines+for+use+in+humans:+present+and+future+perspectives&author=HS+Garmory&author=KA+Brown&author=RW+Titball&publication_year=2002&hl=en'],,, Garmory 2002 ,additional,CD001261-bbs2-0095,
CD001261-bib-0118,"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falek‐Ytter Y, Alonso‐Coello P, et al. ",GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ ,2008,336,    ,['citation-journal']," Guyatt GH, Oxman AD, Vist GE, Kunz R, Falek‐Ytter Y, Alonso‐Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.  BMJ 2008;336(7650):924‐6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.39489.470347.AD', 'https://www.ncbi.nlm.nih.gov/pubmed/18436948', 'https://scholar.google.com/scholar_lookup?title=GRADE:+an+emerging+consensus+on+rating+quality+of+evidence+and+strength+of+recommendations&author=GH+Guyatt&author=AD+Oxman&author=GE+Vist&author=R+Kunz&author=Y+Falek‐Ytter&author=P+Alonso‐Coello&publication_year=2008&hl=en']",18436948,https://doi.org/10.1136/bmj.39489.470347.AD, Guyatt 2008 ,additional,CD001261-bbs2-0096,
CD001261-bib-0119,"Higgins JPT, Green S, editor(s). ","Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org. The Cochrane Collaboration.   ,['citation-other']," Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration.    ",[],,, Higgins 2011 ,additional,CD001261-bbs2-0097,
CD001261-bib-0120,"Jensenius M, Han PV, Schlagenhauf P, Schwartz E, Parola P, Castelli F, et al. ","Acute and potentially life‐threatening tropical diseases in western travelers—a GeoSentinel multicenter study, 1996–2011", American Journal of Tropical Medicine and Hygiene ,2013,88,    ,['citation-journal']," Jensenius M, Han PV, Schlagenhauf P, Schwartz E, Parola P, Castelli F, et al. Acute and potentially life‐threatening tropical diseases in western travelers—a GeoSentinel multicenter study, 1996–2011.  American Journal of Tropical Medicine and Hygiene 2013;88(2):397‐404.    Link to article     Google Scholar     ","['https://doi.org/10.4269/ajtmh.12-0551', 'https://scholar.google.com/scholar_lookup?title=Acute+and+potentially+life‐threatening+tropical+diseases+in+western+travelers—a+GeoSentinel+multicenter+study,+1996–2011+&author=M+Jensenius&author=PV+Han&author=P+Schlagenhauf&author=E+Schwartz&author=P+Parola&author=F+Castelli&publication_year=2013&hl=en']",,https://doi.org/10.4269/ajtmh.12-0551, Jensenius 2013 ,additional,CD001261-bbs2-0098,
CD001261-bib-0121,"Jüni P, Altman DG, Egger M. ",Systematic reviews in healthcare: assessing the quality of controlled trials, BMJ ,2001,323,    ,['citation-journal']," Jüni P, Altman DG, Egger M. Systematic reviews in healthcare: assessing the quality of controlled trials.  BMJ 2001;323(7303):42‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.323.7303.42', 'https://scholar.google.com/scholar_lookup?title=Systematic+reviews+in+healthcare:+assessing+the+quality+of+controlled+trials&author=P+Jüni&author=DG+Altman&author=M+Egger&publication_year=2001&hl=en']",,https://doi.org/10.1136/bmj.323.7303.42, Jüni 2001 ,additional,CD001261-bbs2-0099,
CD001261-bib-0122,"Kariuki S, Gordon MA, Feasey N, Parry CM. ",Antimicrobial resistance and management of invasive Salmonella disease, Vaccine ,2015,33,    ,['citation-journal']," Kariuki S, Gordon MA, Feasey N, Parry CM. Antimicrobial resistance and management of invasive Salmonella disease.  Vaccine 2015;33(3):C21‐9.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.vaccine.2015.03.102', 'https://scholar.google.com/scholar_lookup?title=Antimicrobial+resistance+and+management+of+invasive+Salmonella+disease&author=S+Kariuki&author=MA+Gordon&author=N+Feasey&author=CM+Parry&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.vaccine.2015.03.102, Kariuki 2015 ,additional,CD001261-bbs2-0100,
CD001261-bib-0123,"Keddy KH, Sooka A, Letsoalo ME, Hoyland G, Chaignat CL, Morrissey AB, Crump JA. ",Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub‐Saharan African sites, Bulletin of the World Health Organization ,2011,89,    ,['citation-journal']," Keddy KH, Sooka A, Letsoalo ME, Hoyland G, Chaignat CL, Morrissey AB, Crump JA. Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub‐Saharan African sites.  Bulletin of the World Health Organization 2011;89(9):640‐7.    Link to article     Google Scholar     ","['https://doi.org/10.2471/BLT.11.087627', 'https://scholar.google.com/scholar_lookup?title=Sensitivity+and+specificity+of+typhoid+fever+rapid+antibody+tests+for+laboratory+diagnosis+at+two+sub‐Saharan+African+sites+&author=KH+Keddy&author=A+Sooka&author=ME+Letsoalo&author=G+Hoyland&author=CL+Chaignat&author=AB+Morrissey&author=JA+Crump&publication_year=2011&hl=en']",,https://doi.org/10.2471/BLT.11.087627, Keddy 2011 ,additional,CD001261-bbs2-0101,
CD001261-bib-0124,"MacLennan CA, Martin LB, Micoli F. ",Vaccines against invasive Salmonella disease: current status and future directions, Human Vaccines & Immunotherapeutics ,2014,10,    ,['citation-journal']," MacLennan CA, Martin LB, Micoli F. Vaccines against invasive Salmonella disease: current status and future directions.  Human Vaccines & Immunotherapeutics 2014;10(6):1478‐93.    Link to article     Google Scholar     ","['https://doi.org/10.4161/hv.29054', 'https://scholar.google.com/scholar_lookup?title=Vaccines+against+invasive+Salmonella+disease:+current+status+and+future+directions&author=CA+MacLennan&author=LB+Martin&author=F+Micoli&publication_year=2014&hl=en']",,https://doi.org/10.4161/hv.29054, MacLennan 2014 ,additional,CD001261-bbs2-0102,
CD001261-bib-0125,"Mandell GL, Bennett JE, Dolin R, editors. ",,"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases",2005,,.   ,['citation-book']," Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th Edition. New York: Elsevier/Churchill Livingstone, 2005.    ",[],,, Mandell 2005 ,additional,CD001261-bbs2-0103,
CD001261-bib-0126,Maurice J. ,A first step in bringing typhoid fever out of the closet, Lancet ,2012,379,    ,['citation-journal'], Maurice J. A first step in bringing typhoid fever out of the closet.  Lancet 2012;379(9817):699‐700.    Link to article     Google Scholar     ,"['https://doi.org/10.1016/S0140-6736(12)60294-3', 'https://scholar.google.com/scholar_lookup?title=A+first+step+in+bringing+typhoid+fever+out+of+the+closet&author=J+Maurice&publication_year=2012&hl=en']",,https://doi.org/10.1016/S0140-6736(12)60294-3, Maurice 2012 ,additional,CD001261-bbs2-0104,
CD001261-bib-0127,"Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, et al. ","Burden of typhoid fever in low‐income and middle‐income countries: a systematic, literature‐based update with risk‐factor adjustment", Lancet Global Health ,2014,2,    ,['citation-journal']," Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, et al. Burden of typhoid fever in low‐income and middle‐income countries: a systematic, literature‐based update with risk‐factor adjustment.  Lancet Global Health 2014;2(10):e570‐80.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S2214-109X(14)70301-8', 'https://scholar.google.com/scholar_lookup?title=Burden+of+typhoid+fever+in+low‐income+and+middle‐income+countries:+a+systematic,+literature‐based+update+with+risk‐factor+adjustment+&author=V+Mogasale&author=B+Maskery&author=RL+Ochiai&author=JS+Lee&author=VV+Mogasale&author=E+Ramani&publication_year=2014&hl=en']",,https://doi.org/10.1016/S2214-109X(14)70301-8, Mogasale 2014 ,additional,CD001261-bbs2-0105,
CD001261-bib-0128,"Ochiai L, Acosta C, Agtini M, Bhattacharya S, Bhutta Z, Do C, et al. ",The use of typhoid vaccines in Asia: the DOMI experience, Clinical Infectious Diseases ,2007,45,    ,['citation-journal']," Ochiai L, Acosta C, Agtini M, Bhattacharya S, Bhutta Z, Do C, et al. The use of typhoid vaccines in Asia: the DOMI experience.  Clinical Infectious Diseases 2007;45(Suppl 1):S34‐38.    Link to article     Google Scholar     ","['https://doi.org/10.1086/518144', 'https://scholar.google.com/scholar_lookup?title=The+use+of+typhoid+vaccines+in+Asia:+the+DOMI+experience&author=L+Ochiai&author=C+Acosta&author=M+Agtini&author=S+Bhattacharya&author=Z+Bhutta&author=C+Do&publication_year=2007&hl=en']",,https://doi.org/10.1086/518144, Ochiai 2007 ,additional,CD001261-bbs2-0106,
CD001261-bib-0129,"Ochiai RL, Acosta CJ, Danovaro‐Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, et al. ",A study of typhoid fever in five Asian countries: disease burden and implications for controls, Bulletin of the World Health Organization ,2008,86,    ,['citation-journal']," Ochiai RL, Acosta CJ, Danovaro‐Holliday MC, Baiqing D, Bhattacharya SK, Agtini MD, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls.  Bulletin of the World Health Organization 2008;86(4):260‐8.    Link to article     Google Scholar     ","['https://doi.org/10.2471/BLT.06.039818', 'https://scholar.google.com/scholar_lookup?title=A+study+of+typhoid+fever+in+five+Asian+countries:+disease+burden+and+implications+for+controls+&author=RL+Ochiai&author=CJ+Acosta&author=MC+Danovaro‐Holliday&author=D+Baiqing&author=SK+Bhattacharya&author=MD+Agtini&publication_year=2008&hl=en']",,https://doi.org/10.2471/BLT.06.039818, Ochiai 2008 ,additional,CD001261-bbs2-0107,
CD001261-bib-0130,"Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. ",Typhoid fever, New England Journal of Medicine ,2002,347,    ,['citation-journal']," Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever.  New England Journal of Medicine 2002;347(22):1770‐82.    Link to article     Google Scholar     ","['https://doi.org/10.1056/NEJMra020201', 'https://scholar.google.com/scholar_lookup?title=Typhoid+fever&author=CM+Parry&author=TT+Hien&author=G+Dougan&author=NJ+White&author=JJ+Farrar&publication_year=2002&hl=en']",,https://doi.org/10.1056/NEJMra020201, Parry 2002 ,additional,CD001261-bbs2-0108,
CD001261-bib-0131,"Qamar FN, Azmatullah A, Bhutta ZA. ",Challenges in measuring complications and death due to invasive Salmonella infections, Vaccine ,2015,33,    ,['citation-journal']," Qamar FN, Azmatullah A, Bhutta ZA. Challenges in measuring complications and death due to invasive Salmonella infections.  Vaccine 2015;33(3):C16‐20.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.vaccine.2015.03.103', 'https://scholar.google.com/scholar_lookup?title=Challenges+in+measuring+complications+and+death+due+to+invasive+Salmonella+infections&author=FN+Qamar&author=A+Azmatullah&author=ZA+Bhutta&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.vaccine.2015.03.103, Qamar 2015 ,additional,CD001261-bbs2-0109,
CD001261-bib-0132,"Nordic Cochrane Centre, The Cochrane Collaboration. ",Review Manager (RevMan),,2014,,.   ,['citation-other']," Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.    ",[],,, RevMan 2014 [Computer program] ,additional,CD001261-bbs2-0110,
CD001261-bib-0133,"Saha SK, Baqui AH, Hanif M, Darmstadt GL, Ruhulamin M, Nagatake T, et al. ",Typhoid fever in Bangladesh: implications for vaccination policy, Pediatric Infectious Disease Journal ,2001,20,    ,['citation-journal']," Saha SK, Baqui AH, Hanif M, Darmstadt GL, Ruhulamin M, Nagatake T, et al. Typhoid fever in Bangladesh: implications for vaccination policy.  Pediatric Infectious Disease Journal 2001;20(5):521‐4.    Link to article     Google Scholar     ","['https://doi.org/10.1097/00006454-200105000-00010', 'https://scholar.google.com/scholar_lookup?title=Typhoid+fever+in+Bangladesh:+implications+for+vaccination+policy&author=SK+Saha&author=AH+Baqui&author=M+Hanif&author=GL+Darmstadt&author=M+Ruhulamin&author=T+Nagatake&publication_year=2001&hl=en']",,https://doi.org/10.1097/00006454-200105000-00010, Saha 2001 ,additional,CD001261-bbs2-0111,
CD001261-bib-0134,"Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. ","Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials", Annals of Internal Medicine ,2012,157,    ,['citation-journal']," Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.  Annals of Internal Medicine 2012;157(6):429‐38.    Link to article     Google Scholar     ","['https://doi.org/10.7326/0003-4819-157-6-201209180-00537', 'https://scholar.google.com/scholar_lookup?title=Influence+of+reported+study+design+characteristics+on+intervention+effect+estimates+from+randomized,+controlled+trials+&author=J+Savović&author=HE+Jones&author=DG+Altman&author=RJ+Harris&author=P+Jüni&author=J+Pildal&publication_year=2012&hl=en']",,https://doi.org/10.7326/0003-4819-157-6-201209180-00537, Savović 2012 ,additional,CD001261-bbs2-0112,
CD001261-bib-0135,"Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, et al. ",Typhoid fever in children aged less than 5 years, Lancet ,1999,354,    ,['citation-journal']," Sinha A, Sazawal S, Kumar R, Sood S, Reddaiah VP, Singh B, et al. Typhoid fever in children aged less than 5 years.  Lancet 1999;354(9180):734‐7.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(98)09001-1', 'https://scholar.google.com/scholar_lookup?title=Typhoid+fever+in+children+aged+less+than+5+years&author=A+Sinha&author=S+Sazawal&author=R+Kumar&author=S+Sood&author=VP+Reddaiah&author=B+Singh&publication_year=1999&hl=en']",,https://doi.org/10.1016/S0140-6736(98)09001-1, Sinha 1999 ,additional,CD001261-bbs2-0113,
CD001261-bib-0136,"Steele AD, Burgess DC, Diaz Z, Carey ME, Zaidi AK. ",Challenges and opportunities for typhoid fever control: a call for coordinated action, Clinical Infectious Diseases ,2016,62,    ,['citation-journal']," Steele AD, Burgess DC, Diaz Z, Carey ME, Zaidi AK. Challenges and opportunities for typhoid fever control: a call for coordinated action.  Clinical Infectious Diseases 2016;62(1):S4‐8.    Link to article     Google Scholar     ","['https://doi.org/10.1093/cid/civ976', 'https://scholar.google.com/scholar_lookup?title=Challenges+and+opportunities+for+typhoid+fever+control:+a+call+for+coordinated+action&author=AD+Steele&author=DC+Burgess&author=Z+Diaz&author=ME+Carey&author=AK+Zaidi&publication_year=2016&hl=en']",,https://doi.org/10.1093/cid/civ976, Steele 2016 ,additional,CD001261-bbs2-0114,
CD001261-bib-0137,"Thriemer K, Ley B, Menten J, Jacobs J, van den Ende J. ","Review and meta‐analysis of the performance of two point of care typhoid fever tests, Tubex TF and Typhidot, in endemic countries", PLOS ONE ,2013,8,    ,['citation-journal']," Thriemer K, Ley B, Menten J, Jacobs J, van den Ende J. Review and meta‐analysis of the performance of two point of care typhoid fever tests, Tubex TF and Typhidot, in endemic countries.  PLOS ONE 2013;8(12):e81263.    Link to article     Google Scholar     ","['https://doi.org/10.1371/journal.pone.0081263', 'https://scholar.google.com/scholar_lookup?title=Review+and+meta‐analysis+of+the+performance+of+two+point+of+care+typhoid+fever+tests,+Tubex+TF+and+Typhidot,+in+endemic+countries+&author=K+Thriemer&author=B+Ley&author=J+Menten&author=J+Jacobs&author=J+Ende&publication_year=2013&hl=en']",,https://doi.org/10.1371/journal.pone.0081263, Thriemer 2013 ,additional,CD001261-bbs2-0115,
CD001261-bib-0138,"Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL. ",Typhoid Fever, Lancet ,2015,385,    ,['citation-journal']," Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL. Typhoid Fever.  Lancet 2015;385(9973):1136‐45.    Link to article     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(13)62708-7', 'https://scholar.google.com/scholar_lookup?title=Typhoid+Fever&author=J+Wain&author=RS+Hendriksen&author=ML+Mikoleit&author=KH+Keddy&author=RL+Ochiai&publication_year=2015&hl=en']",,https://doi.org/10.1016/S0140-6736(13)62708-7, Wain 2015 ,additional,CD001261-bbs2-0116,
CD001261-bib-0139,World Health Organization. ,Typhoid vaccines: WHO position paper, Weekly Epidemiological Record ,2000,75,(32):257‐64.   ,['citation-journal'], World Health Organization. Typhoid vaccines: WHO position paper.  Weekly Epidemiological Record 2000;75(32):257‐64.    ,[],,, WHO 2000 ,additional,CD001261-bbs2-0117,
CD001261-bib-0140,"Initiative for Vaccines Research, World Health Organization. ",Diarrhoeal diseases,State of the Art of Vaccine Research and Development,2005,,.   ,['citation-book']," Initiative for Vaccines Research, World Health Organization. Diarrhoeal diseases. State of the Art of Vaccine Research and Development. Geneva: World Health Organization, 2005.    ",[],,, WHO 2005 ,additional,CD001261-bbs2-0118,
CD001261-bib-0141,World Health Organization. ,Typhoid vaccine: WHO position paper, Weekly Epidemiological Record ,2008,83,(6):49‐60.   ,['citation-journal'], World Health Organization. Typhoid vaccine: WHO position paper.  Weekly Epidemiological Record 2008;83(6):49‐60.    ,[],,, WHO 2008 ,additional,CD001261-bbs2-0119,
CD001261-bib-0142,World Health Organization. ,Tyhoid vaccines: WHO position paper ‐ March 2018,,2018,,).   ,['citation-other']," World Health Organization. Tyhoid vaccines: WHO position paper ‐ March 2018. Weekly Epidemiological Record2018; Vol. 93, issue 13:154‐72, Available from: apps.who.int/iris/bitstream/handle/10665/272272/WER9313.pdf?ua=1 (last accessed 23 April 2018).    ",[],,, WHO 2018a ,additional,CD001261-bbs2-0120,
CD001261-bib-0143,World Health Organization. ,Table 1: Summary of WHO position papers ‐ recommendations for routine immunization,,,,. cdrwww.who.int/immunization/policy/Immunization_routine_table1.pdf Updated April 2018 (accessed 30 April 2018).   ,['citation-other'], World Health Organization. Table 1: Summary of WHO position papers ‐ recommendations for routine immunization. cdrwww.who.int/immunization/policy/Immunization_routine_table1.pdf Updated April 2018 (accessed 30 April 2018).    ,[],,, WHO 2018b ,additional,CD001261-bbs2-0121,
CD001261-bib-0144,WHO Strategic Advisory Group of Experts (SAGE) on Immunization. ,Summary of the October 2017 meeting of the Strategic Advisory Group of Experts on Immunization. October 2017,,,,. www.who.int/immunization/policy/sage/SAGE_oct_2017_meeting_summary.pdf?ua=1 (accessed prior to 31 October 2017).   ,['citation-other'], WHO Strategic Advisory Group of Experts (SAGE) on Immunization. Summary of the October 2017 meeting of the Strategic Advisory Group of Experts on Immunization. October 2017. www.who.int/immunization/policy/sage/SAGE_oct_2017_meeting_summary.pdf?ua=1 (accessed prior to 31 October 2017).    ,[],,, WHO SAGE 2017 ,additional,CD001261-bbs2-0122,
CD001261-bib-0145,"Anwar E, Goldberg E, Fraser A, Acosta CJ, Paul M, Leibovici L. ",Vaccines for preventing typhoid fever, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Anwar E, Goldberg E, Fraser A, Acosta CJ, Paul M, Leibovici L. Vaccines for preventing typhoid fever.  Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD001261.pub3]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD001261.pub3', 'https://scholar.google.com/scholar_lookup?title=Vaccines+for+preventing+typhoid+fever&author=E+Anwar&author=E+Goldberg&author=A+Fraser&author=CJ+Acosta&author=M+Paul&author=L+Leibovici&publication_year=2014&hl=en']",,https://doi.org/10.1002/14651858.CD001261.pub3, Anwar 2014 ,other_versions,CD001261-bbs2-0123,
CD001261-bib-0146,"Engels EA, Lau J. ",Vaccines for preventing typhoid fever, Cochrane Database of Systematic Reviews ,1998,,    ,['citation-journal']," Engels EA, Lau J. Vaccines for preventing typhoid fever.  Cochrane Database of Systematic Reviews 1998, Issue 4. [DOI: 10.1002/14651858.CD001261]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD001261', 'https://scholar.google.com/scholar_lookup?title=Vaccines+for+preventing+typhoid+fever&author=EA+Engels&author=J+Lau&publication_year=1998&hl=en']",,https://doi.org/10.1002/14651858.CD001261, Engels 1998a ,other_versions,CD001261-bbs2-0124,
CD001261-bib-0147,"Engels EA, Falagas MA, Lau J, Bennish ML. ",Typhoid fever vaccines: a meta‐analysis of efficacy and toxicity studies, BMJ ,1998,316,    ,['citation-journal']," Engels EA, Falagas MA, Lau J, Bennish ML. Typhoid fever vaccines: a meta‐analysis of efficacy and toxicity studies.  BMJ 1998;316(7125):110‐6.    Link to article     Google Scholar     ","['https://doi.org/10.1136/bmj.316.7125.110', 'https://scholar.google.com/scholar_lookup?title=Typhoid+fever+vaccines:+a+meta‐analysis+of+efficacy+and+toxicity+studies&author=EA+Engels&author=MA+Falagas&author=J+Lau&author=ML+Bennish&publication_year=1998&hl=en']",,https://doi.org/10.1136/bmj.316.7125.110, Engels 1998b ,other_versions,CD001261-bbs2-0125,
CD001261-bib-0148,"Fraser A, Goldberg E, Acosta CJ, Paul M, Leibovici L. ",Vaccines for preventing typhoid fever, Cochrane Database of Systematic Reviews ,2007,,    ,['citation-journal']," Fraser A, Goldberg E, Acosta CJ, Paul M, Leibovici L. Vaccines for preventing typhoid fever.  Cochrane Database of Systematic Reviews 2007, Issue 4. Art No: CD001261. [DOI: 10.1002/14651858.CD001261.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD001261.pub2', 'https://scholar.google.com/scholar_lookup?title=Vaccines+for+preventing+typhoid+fever&author=A+Fraser&author=E+Goldberg&author=CJ+Acosta&author=M+Paul&author=L+Leibovici&publication_year=2007&hl=en']",,https://doi.org/10.1002/14651858.CD001261.pub2, Fraser 2007a ,other_versions,CD001261-bbs2-0126,
CD001261-bib-0149,"Fraser A, Paul M, Goldberg E, Acosta CJ, Leibovici L. ",Typhoid fever vaccines: systematic review and meta‐analysis of randomised controlled trials, Vaccine ,2007,25,    ,['citation-journal']," Fraser A, Paul M, Goldberg E, Acosta CJ, Leibovici L. Typhoid fever vaccines: systematic review and meta‐analysis of randomised controlled trials.  Vaccine 2007;25(45):7848‐57.    Link to article     Google Scholar     ","['https://doi.org/10.1016/j.vaccine.2007.08.027', 'https://scholar.google.com/scholar_lookup?title=Typhoid+fever+vaccines:+systematic+review+and+meta‐analysis+of+randomised+controlled+trials+&author=A+Fraser&author=M+Paul&author=E+Goldberg&author=CJ+Acosta&author=L+Leibovici&publication_year=2007&hl=en']",,https://doi.org/10.1016/j.vaccine.2007.08.027, Fraser 2007b ,other_versions,CD001261-bbs2-0127,
